Misplaced Pages

Latest revision as of 23:18, 6 December 2024

An electronic cigarette (e-cigarette), commonly called a vape, is a device that simulates tobacco smoking. It consists of an atomizer, a power source such as a battery, and a container such as a cartridge or tank. Instead of smoke, the user inhales vapor. As such, using an e-cigarette is often called "vaping". The atomizer is a heating element that vaporizes a liquid solution called e-liquid, which quickly cools into an aerosol of tiny droplets, vapor and air. The vapor mainly comprises propylene glycol and/or glycerin, usually with nicotine and flavoring. Its exact composition varies, and depends on several things including user behavior.

E-cigarettes are activated by taking a puff or pressing a button. Some look like traditional cigarettes, and most kinds are reusable.

Nicotine is highly addictive. Users become physically and psychologically dependent. Scientists do not know how harmful e-cigarettes are over the long-term because it is hard to separate the effects of vaping from the effects of smoking when so many people both vape and smoke. E-cigarettes have not been used widely enough or for long enough to be sure.

Vaping is likely far less harmful than smoking, but still harmful. E-cigarette vapor contains far fewer toxins than cigarette smoke, and at much lower concentrations. The vapor contains traces of harmful substances not found in cigarette smoke. E-cigarettes containing nicotine are more effective than nicotine replacement therapy (NRT) for smoking cessation. However, e-cigarettes have not been subject to the same rigorous testing that most nicotine replacement therapy products have, and health warnings may encourage a smoker to quit vaping.

Construction

An electronic cigarette consists of an atomizer, a power source such as a battery, and a container for e-liquid such as a cartridge or tank.

E-cigarettes have evolved over time, and the different designs are classified in generations. First-generation e-cigarettes tend to look like traditional cigarettes and are called "cigalikes". Second-generation devices are larger and look less like traditional cigarettes. Third-generation devices include mechanical mods and variable voltage devices. The fourth-generation includes sub-ohm tanks (meaning they have electrical resistance of less than 1 ohm) and temperature control. There are also pod mod devices that use protonated nicotine, rather than free-base nicotine found in earlier generations, providing higher nicotine yields.

E-liquid

The mixture used in vapor products such as e-cigarettes is called e-liquid. E-liquid formulations vary widely. A typical e-liquid is composed of propylene glycol and glycerin (95%) and a combination of flavorings, nicotine, and other additives (5%). The flavorings may be natural, artificial, or organic. Over 80 harmful chemicals such as formaldehyde and metallic nanoparticles have been found in e-liquids at trace quantities. There are many e-liquid manufacturers, and more than 15,000 flavors.

Many countries regulate what e-liquids can contain. In the US, there are Food and Drug Administration (FDA) compulsory manufacturing standards and American E-liquid Manufacturing Standards Association (AEMSA) recommended manufacturing standards. European Union standards are published in the EU Tobacco Products Directive.

Coils

In 2019 a study found that the metal coils of e-cigarettes can leach metal into the e-liquid leading to permanent lung damage in some cases. Research has shown that higher voltages generate more heat and release more toxic substances into the e-liquid. Vaping cannabis usually involves higher temperatures than nicotine.

Use

Popularity

Since entering the market around 2003, e-cigarette use has risen rapidly. In 2011 there were about 7 million adult e-cigarette users globally, increasing to 68 million in 2020 compared with 1.1 billion cigarette smokers. There was a further rise to 82 million e-cigarette users in 2021. This increase has been attributed to targeted marketing, lower cost compared to conventional cigarettes, and the better safety profile of e-cigarettes compared to tobacco. E-cigarette use is highest in China, the US, and Europe, with China having the most users.

Motivation

There are varied reasons for e-cigarette use. Most users are trying to quit smoking, but a large proportion of use is recreational or as an attempt to get around smoke-free laws. Many people vape because they believe vaping is safer than smoking. The wide choice of flavors and lower price compared to cigarettes are also important factors.

Other motivations include reduced odor and fewer stains. E-cigarettes also appeal to technophiles who enjoy customizing their devices.

Gateway theory

The gateway hypothesis is the idea that using less harmful drugs can lead to more harmful ones. Evidence shows that many users who begin by vaping will go on to also smoke traditional cigarettes. People with mental illnesses, who as a group are more susceptible to nicotine addiction, are at particularly high risk of dual use.

However, an association between vaping and subsequent smoking does not necessarily imply a causal gateway effect. Instead, people may have underlying characteristics that predispose them to both activities. There is a genetic association between smoking, vaping, gambling, promiscuity and other risk-taking behaviors. Young people with poor executive functioning use e-cigarettes, cigarettes, and alcohol at higher rates than their peers. E-cigarette users are also more likely to use both cannabis and unprescribed Adderall or Ritalin. Longitudinal studies of e-cigarettes and smoking have been criticized for failing to adequately control for these and other confounding factors.

Smoking rates have continually declined as e-cigarettes have grown in popularity, especially among young people, suggesting that there is little evidence for a gateway effect at the population level. This observation has been criticized, however, for ignoring the effect of anti-smoking interventions.

Young adult and teen use

Worldwide, increasing numbers of young people are vaping. With access to e-cigarettes, young people's tobacco use has dropped by about 75%.

Most young e-cigarette users have never smoked, but there is a substantial minority who both vape and smoke. Many young people who would not smoke are vaping. Young people who smoke tobacco or marijuana, or who drink alcohol, are much more likely to vape. Among young people who have tried vaping, most used a flavored product the first time.

Vaping correlates with smoking among young people, even in those who would otherwise be unlikely to smoke. Experimenting with vaping encourages young people to continue smoking. A 2015 study found minors had little resistance to buying e-cigarettes online. Teenagers may not admit to using e-cigarettes, but use, for instance, a hookah pen. As a result, self-reporting may be lower in surveys.

More recent studies show a trend of an increasing proportion of young people who use e-cigarettes. In 2018, 20% of high school students were using e-cigarettes. In 2020, however, this number increased to 50% of high school students reported to have used e-cigarettes. Similarly, in Canada, there has been trend showing 29% of young people reporting to have used e-cigarettes in 2017, increasing to 37% in 2018.

Health effects

The health risks of e-cigarettes are not known for certain, but the risk of serious adverse events is thought to be low, and e-cigarettes are likely safer than combusted tobacco products. However, this does not mean that e-cigarettes are harmless. E-cigarette use is associated with increased risk of chronic obstructive pulmonary disease, asthma, chronic bronchitis, and emphysema. Those who use e-cigarettes daily have higher risk than those who use them occasionally. According to the National Academies of Sciences, Engineering, and Medicine, "Laboratory tests of e-cigarette ingredients, in vitro toxicological tests, and short-term human studies suggest that e-cigarettes are likely to be far less harmful than combustible tobacco cigarettes." Randomized controlled trials provide "high-certainty" evidence that e-cigarettes containing nicotine are more effective than nicotine replacement therapy for discontinuing tobacco smoking, and moderate‐certainty evidence that they are more effective than e-cigarettes free of nicotine.

Some of the most common but less serious adverse effects include abdominal pain, headache, blurry vision, throat and mouth irritation, vomiting, nausea, and coughing. Nicotine is addictive and harmful to fetuses, children, and young people. In 2019 and 2020, an outbreak of severe vaping lung illness in the US was strongly linked to vitamin E acetate by the CDC. While it is still widely debated which particular component of vape liquid is the cause of illness, vitamin E acetate, specifically, has been identified as a potential culprit in vape-related illnesses. There was likely more than one cause of the outbreak.

E-cigarettes produce similar levels of particulates to tobacco cigarettes. There is "only limited evidence showing adverse respiratory and cardiovascular effects in humans", with the authors of a 2020 review calling for more long-term studies on the subject. E-cigarettes increase the risk of asthma by 40% and chronic obstructive pulmonary disease by 50% compared to not using nicotine at all.

Pregnancy

The British Royal College of Midwives states: "While vaping devices such as electronic cigarettes (e-cigs) do contain some toxins, they are at far lower levels than found in tobacco smoke. If a pregnant woman who has been smoking chooses to use an e-cig and it helps her to quit smoking and stay smokefree, she should be supported to do so." Based on the available evidence on e-cigarette safety, there was also "no reason to believe that use of an e-cig has any adverse effect on breastfeeding." The statement went on to say, "vaping should continue, if it is helpful to quitting smoking and staying smokefree". The UK National Health Service says: "If using an e-cigarette helps you to stop smoking, it is much safer for you and your baby than continuing to smoke." Many women who vape continue to do so during pregnancy because of the perceived safety of e-cigarettes compared to tobacco.

United States

In one of the few studies identified, a 2015 survey of 316 pregnant women in a Maryland clinic found that the majority had heard of e-cigarettes, 13% had used them, and 0.6% were current daily users. These findings are of concern because the dose of nicotine delivered by e-cigarettes can be as high or higher than that delivered by traditional cigarettes.

Data from two states in the Pregnancy Risk Assessment System (PRAMS) show that in 2015—roughly the mid-point of the study period—10.8% of the sample used e-cigarettes in the three months prior to the pregnancy while 7.0%, 5.8%, and 1.4% used these products at the time of the pregnancy, in the first trimester, and at birth respectively. According to National Health Interview Survey (NHIS) data from 2014 to 2017, 38.9% of pregnant smokers used e-cigarettes compared to only 13.5% of non-pregnant, reproductive age women smokers. A health economic study found that passing an e-cigarette minimum legal sale age law in the United States increased teenage prenatal smoking by 0.6 percentage points and had no effect on birth outcomes. Nevertheless, additional research needs to be done on the health effects of electronic cigarette use during pregnancy.

According to the CDC, E-cigarettes are not safe during pregnancy. "Although the aerosol of e-cigarettes generally has fewer harmful substances than cigarette smoke, e-cigarettes and other products containing nicotine are not safe to use during pregnancy. Nicotine is a health danger for pregnant women and developing babies and can damage a developing baby's brain and lungs. Also, some of the flavorings used in e-cigarettes may be harmful to a developing baby."

A popular vaporizer named Juul was widely used by American young people until 2022, when the FDA banned its products from sale. Close to 80% of respondents in a 2017 Truth Initiative study aged 15–24 reported using Juul also used the device in the last 30 days. In the 2010s, US teenagers used the verb "Juuling" to describe vaping, and Juuling was the subject of widespread memes on social media.

Harm reduction

Harm reduction refers to any reduction in harm from a prior level. Harm minimization strives to reduce harms to the lowest achievable level. When a person does not want to quit nicotine, harm minimization means striving to eliminate tobacco exposure by replacing it with vaping. E-cigarettes can reduce smokers' exposure to carcinogens and other toxic chemicals found in tobacco.

Tobacco harm reduction has been a controversial area of tobacco control. Health advocates have been slow to support a harm reduction method out of concern that tobacco companies cannot be trusted to sell products that will lower the risks associated with tobacco use. A large number of smokers want to reduce harm from smoking by using e-cigarettes. The argument for harm reduction does not take into account the adverse effects of nicotine. There cannot be a defensible reason for harm reduction in children who are vaping with a base of nicotine. Quitting smoking is the most effective strategy to tobacco harm reduction.

Tobacco smoke contains 100 known carcinogens and 900 potentially cancer-causing chemicals, but e-cigarette vapor contains less of the potential carcinogens than found in tobacco smoke. A study in 2015 using a third-generation device found levels of formaldehyde were greater than with cigarette smoke when adjusted to a maximum power setting. E-cigarettes cannot be considered safe because there is no safe level for carcinogens. Due to their similarity to traditional cigarettes, e-cigarettes could play a valuable role in tobacco harm reduction. The public health community remains divided concerning the appropriateness of endorsing a device whose safety and efficacy for smoking cessation remain unclear. Overall, the available evidence supports the cautionary implementation of harm reduction interventions aimed at promoting e-cigarettes as attractive and competitive alternatives to cigarette smoking, while taking measures to protect vulnerable groups and individuals.

The core concern is that smokers who could have quit entirely will develop an alternative nicotine addiction. Dual use may be an increased risk to a smoker who continues to use even a minimal amount of traditional cigarettes, rather than quitting. Because of the convenience of e-cigarettes, it may further increase the risk of addiction. The promotion of vaping as a harm reduction aid is premature, while a 2011 review found they appear to have the potential to lower tobacco-related death and disease. Evidence to substantiate the potential of vaping to lower tobacco-related death and disease is unknown. The health benefits of reducing cigarette use while vaping is unclear. E-cigarettes could have an influential role in tobacco harm reduction. The authors warned against the potential harm of excessive regulation and advised health professionals to consider advising smokers who are reluctant to quit by other methods to switch to e-cigarettes as a safer alternative to smoking.

A 2014 review recommended that regulations for e-cigarettes could be similar to those for dietary supplements or cosmetic products to not limit their potential for harm reduction. A 2012 review found e-cigarettes could considerably reduce traditional cigarettes use and they likely could be used as a lower risk replacement for traditional cigarettes, but there is not enough data on their safety and efficacy to draw definite conclusions. There is no research available on vaping for reducing harm in high-risk groups such as people with mental disorders.

A 2014 PHE report concluded that hazards associated with products currently on the market are probably low, and apparently much lower than smoking. However, harms could be reduced further through reasonable product standards. The British Medical Association encourages health professionals to recommend conventional nicotine replacement therapies, but for patients unwilling to use or continue using such methods, health professionals may present e-cigarettes as a lower-risk option than tobacco smoking.

The American Association of Public Health Physicians (AAPHP) suggests those who are unwilling to quit tobacco smoking or unable to quit with medical advice and pharmaceutical methods should consider other nicotine-containing products such as e-cigarettes and smokeless tobacco for long-term use instead of smoking. A 2014 WHO report concluded that some smokers will switch completely to e-cigarettes from traditional tobacco but a "sizeable" number will use both. This report found that such "dual-use" of e-cigarettes and tobacco "will have much smaller beneficial effects on overall survival compared with quitting smoking completely."

Smoking cessation

Whether e-cigarettes help people quit smoking is debated. Limited evidence suggests that e-cigarettes likely do help people to stop smoking when used in clinical settings. However, more smokers become dual users than succeed in complete abstinence. Outside clinical settings, vaping does not greatly change the odds of quitting smoking.

A small number of studies have looked at whether using e-cigarettes reduces the number of cigarettes smokers consume. E-cigarette use may decrease the number of cigarettes smoked, but smoking just one to four cigarettes daily greatly increases the risk of cardiovascular disease compared to not smoking. The extent to which decreasing cigarette smoking with vaping leads to quitting is unknown.

It is unclear whether e-cigarettes are only helpful for particular types of smokers. Vaping with nicotine may reduce tobacco use among daily smokers. Whether vaping is effective for quitting smoking may depend on whether it was used as part of an effort to quit.

One of the challenges in studying e-cigarettes is that there are hundreds of brands and models of e-cigarettes sold that vary in the design and operation of the devices and composition of the liquid, and the technology continues to change. E-cigarettes have not been subjected to the same type of efficacy testing as nicotine replacement products. There are also social concerns - use of e-cigarettes may normalize tobacco use and prolong cigarette use for people who could have quit instead, or it could put extra pressure on smokers to stop cigarette smoking because e-cigarettes are a more socially acceptable alternative. The evidence indicates smokers are more frequently able to completely quit smoking using tank devices compared to cigalikes, which may be due to their more efficient nicotine delivery. One study supports the claim that smokers are more likely to use e-cigarettes as a nicotine replacement product to aid in smoking cessation than other pharmaceutical products.

There is low quality evidence that vaping assists smokers to quit smoking in the long-term compared with nicotine-free vaping. Nicotine-containing e-cigarettes were associated with greater effectiveness for quitting smoking than e-cigarettes without nicotine. A 2013 study in smokers who were not trying to quit, found that vaping, with or without nicotine decreased the number of cigarettes consumed. E-cigarettes without nicotine may reduce tobacco cravings because of the smoking-related physical stimuli.

A 2015 meta-analysis on clinical trials found that e-cigarettes containing nicotine are more effective than nicotine-free ones for quitting smoking. They compared their finding that nicotine-containing e-cigarettes helped 20% of people quit with the results from other studies that found nicotine replacement products helps 10% of people quit. A 2016 review found low quality evidence of a trend towards benefit of e-cigarettes with nicotine for smoking cessation. In terms of whether flavored e-cigarettes assisted quitting smoking, the evidence is inconclusive. Tentative evidence indicates that health warnings on vaping products may influence users to give up vaping.

As of 2020, the efficacy and safety of vaping for quitting smoking during pregnancy was unknown. No research is available to provide details on the efficacy of vaping for quitting smoking during pregnancy. There is robust evidence that vaping is not effective for quitting smoking among adolescents. In view of the shortage of evidence, vaping is not recommend for cancer patients, although for all patients vaping is likely less dangerous than smoking cigarettes. The effectiveness of vaping for quitting smoking among vulnerable groups is uncertain.

Safety

There is no consensus on the risks of e-cigarette use. There is little data about their safety, and a considerable variety of liquids are used as carriers, and thus are present in the aerosol delivered to the user. Reviews of the safety of e-cigarettes have reached quite different conclusions. A 2014 WHO report cautioned about potential risks of using e-cigarettes. Regulated US FDA products such as nicotine inhalers may be safer than e-cigarettes, but e-cigarettes are generally seen as safer than combusted tobacco products such as cigarettes and cigars.

The risk of early death is anticipated to be similar to that of smokeless tobacco. Since vapor does not contain tobacco and does not involve combustion, users may avoid several harmful constituents usually found in tobacco smoke, such as ash, tar, and carbon monoxide. However, e-cigarette use with or without nicotine cannot be considered risk-free because the long-term effects of e-cigarette use are unknown.

The cytotoxicity of e-liquids varies, and contamination with various chemicals have been detected in the liquid. Metal parts of e-cigarettes in contact with the e-liquid can contaminate it with metal particles. Many chemicals including carbonyl compounds such as formaldehyde can inadvertently be produced when the nichrome wire (heating element) that touches the e-liquid is heated and chemically reacted with the liquid. Normal usage of e-cigarettes, and reduced voltage (3.0 V) devices generate very low levels of formaldehyde.

The later-generation and "tank-style" e-cigarettes with a higher voltage (5.0 V) may generate equal or higher levels of formaldehyde compared to smoking. A 2015 report by Public Health England found that high levels of formaldehyde only occurred in overheated "dry-puffing". Users detect the "dry puff" (also known as a "dry hit") and avoid it, and they concluded that "There is no indication that EC users are exposed to dangerous levels of aldehydes." However, e-cigarette users may "learn" to overcome the unpleasant taste due to elevated aldehyde formation, when the nicotine craving is high enough.

Another common chemical found in e-cigarettes is ketene. When it enters the lungs after inhaled, this chemical causes damage to the cellular structure of lung tissue causing the cells to not function at maximum capacity and not absorb gasses as readily. This can cause shortness of breath which can lead to other health conditions such as tachycardia and respiratory failure. E-cigarette users who use devices that contain nicotine are exposed to its potentially harmful effects.

Nicotine is associated with cardiovascular disease, possible birth defects, and poisoning. In vitro studies of nicotine have associated it with cancer, but carcinogenicity has not been demonstrated in vivo. There is inadequate research to show that nicotine is associated with cancer in humans. The risk is probably low from the inhalation of propylene glycol and glycerin. No information is available on the long-term effects of the inhalation of flavors.

In October 2021, researchers at Johns Hopkins University reported over 2,000 unknown chemicals in the vape clouds that they tested from Vuse, Juul, Blu and Mi-Salt vape devices.

In 2019–2020, there was an outbreak of vaping-related lung illness in the US and Canada, primarily related to vaping THC with vitamin E acetate.

E-cigarettes create vapor that consists of fine and ultrafine particles of particulate matter, with the majority of particles in the ultrafine range. The vapor have been found to contain propylene glycol, glycerin, nicotine, flavors, small amounts of toxicants, carcinogens, and heavy metals, as well as metal nanoparticles, and other substances. Many carcinogenic compounds have been detected in e-cigarettes, such as N-Nitrosonornicotine (NNN), N-Nitrosoanatabine (NAT), etc., all of which have been proven to be harmful to human health. Exactly what the vapor consists of varies in composition and concentration across and within manufacturers, and depends on the contents of the liquid, the physical and electrical design of the device, and user behavior, among other factors.

E-cigarette vapor potentially contains harmful chemicals not found in tobacco smoke. The majority of toxic chemicals found in cigarette smoke are absent in e-cigarette vapor. E-cigarette vapor contains lower concentrations of potentially toxic chemicals than with cigarette smoke. Those which are present, are mostly below 1% of the corresponding levels permissible by workplace safety standards. But workplace safety standards do not recognize exposure to certain vulnerable groups such as people with medical ailments, children, and infants who may be exposed to second-hand vapor.

Concern exists that some of the mainstream vapor exhaled by e-cigarette users may be inhaled by bystanders, particularly indoors, although e-cigarette pollutant levels are much lower than for cigarettes and likely to pose a much lower risk, if any, compared to cigarettes. E-cigarette use by a parent might lead to inadvertent health risks to offspring. A 2014 review recommended that e-cigarettes should be regulated for consumer safety. There is limited information available on the environmental issues around production, use, and disposal of e-cigarettes that use cartridges. E-cigarettes that are not reusable may contribute to the problem of electronic waste.

Addiction

Nicotine, a key ingredient in most e-liquids, is well-recognized as one of the most addictive substances, as addictive as heroin and cocaine. Addiction is believed to be a disorder of experience-dependent brain plasticity. The reinforcing effects of nicotine play a significant role in the beginning and continuing use of the drug. First-time nicotine users develop a dependence about 32% of the time. Chronic nicotine use involves both psychological and physical dependence. Nicotine-containing e-cigarette vapor induces addiction-related neurochemical, physiological and behavioral changes. Nicotine affects neurological, neuromuscular, cardiovascular, respiratory, immunological and gastrointestinal systems.

Neuroplasticity within the brain's reward system occurs as a result of long-term nicotine use, leading to nicotine dependence. The neurophysiological activities that are the basis of nicotine dependence are intricate. It includes genetic components, age, gender, and the environment. Nicotine addiction is a disorder which alters different neural systems such as dopaminergic, glutamatergic, GABAergic, serotoninergic, that take part in reacting to nicotine. Long-term nicotine use affects a broad range of genes associated with neurotransmission, signal transduction, and synaptic architecture. The ability to quitting smoking is affected by genetic factors, including genetically based differences in the way nicotine is metabolized.

Nicotine is a parasympathomimetic stimulant that binds to and activates nicotinic acetylcholine receptors in the brain, which subsequently causes the release of dopamine and other neurotransmitters, such as norepinephrine, acetylcholine, serotonin, gamma-aminobutyric acid, glutamate, endorphins, and several neuropeptides, including proopiomelanocortin-derived α-MSH and adrenocorticotropic hormone. Corticotropin-releasing factor, Neuropeptide Y, orexins, and norepinephrine are involved in nicotine addiction. Continuous exposure to nicotine can cause an increase in the number of nicotinic receptors, which is believed to be a result of receptor desensitization and subsequent receptor upregulation.

Long-term exposure to nicotine can also result in downregulation of glutamate transporter 1. Long-term nicotine exposure upregulates cortical nicotinic receptors, but it also lowers the activity of the nicotinic receptors in the cortical vasodilation region. These effects are not easily understood. With constant use of nicotine, tolerance occurs at least partially as a result of the development of new nicotinic acetylcholine receptors in the brain.

After several months of nicotine abstinence, the number of receptors go back to normal. The extent to which alterations in the brain caused by nicotine use are reversible is not fully understood. Nicotine also stimulates nicotinic acetylcholine receptors in the adrenal medulla, resulting in increased levels of epinephrine and beta-endorphin. Its physiological effects stem from the stimulation of nicotinic acetylcholine receptors, which are located throughout the central and peripheral nervous systems.

When nicotine intake stops, the upregulated nicotinic acetylcholine receptors induce withdrawal symptoms. These symptoms can include cravings for nicotine, anger, irritability, anxiety, depression, impatience, trouble sleeping, restlessness, hunger, weight gain, and difficulty concentrating. When trying to quit smoking with vaping a base containing nicotine, symptoms of withdrawal can include irritability, restlessness, poor concentration, anxiety, depression, and hunger. The changes in the brain cause a nicotine user to feel abnormal when not using nicotine. In order to feel normal, the user has to keep his or her body supplied with nicotine. E-cigarettes may reduce cigarette craving and withdrawal symptoms.

It is not clear whether e-cigarette use will decrease or increase overall nicotine addiction, but the nicotine content in e-cigarettes is adequate to sustain nicotine dependence. Chronic nicotine use causes a broad range of neuroplastic adaptations, making quitting hard to accomplish. A 2015 study found that users vaping non-nicotine e-liquid exhibited signs of dependence. Experienced users tend to take longer puffs which may result in higher nicotine intake. It is difficult to assess the impact of nicotine dependence from e-cigarette use because of the wide range of e-cigarette products. The addiction potential of e-cigarettes may have risen because as they have progressed, they have delivered nicotine better.

A 2015 American Academy of Pediatrics (AAP) policy statement stressed "the potential for these products to addict a new generation of youth to nicotine and reverse more than 50 years of public health gains in tobacco control." The World Health Organization (WHO) is concerned about starting nicotine use among non-smokers, and the National Institute on Drug Abuse said e-cigarettes could maintain nicotine addiction in those who are attempting to quit. The limited available data suggests that the likelihood of excessive use of e-cigarettes is smaller than traditional cigarettes. No long-term studies have been done on the effectiveness of e-cigarettes in treating tobacco addiction, but some evidence suggests that dual use of e-cigarettes and traditional cigarettes may be associated with greater nicotine dependence.

There is concern that children may progress from vaping to smoking. Adolescents are likely to underestimate nicotine's addictiveness. Vulnerability to the brain-modifying effects of nicotine, along with youthful experimentation with e-cigarettes, could lead to a lifelong addiction. A long-term nicotine addiction from using a vape may result in using other tobacco products. The majority of addiction to nicotine starts during youth and young adulthood. Adolescents are more likely to become nicotine dependent than adults.

The adolescent brain seems to be particularly sensitive to neuroplasticity as a result of nicotine. Minimal exposure could be enough to produce neuroplastic alterations in the very sensitive adolescent brain. A 2014 review found that in studies up to a third of young people who have not tried a traditional cigarette have used e-cigarettes. The degree to which teens are using e-cigarettes in ways the manufacturers did not intend, such as increasing the nicotine delivery, is unknown, as is the extent to which e-cigarette use may lead to addiction or substance dependence in young people.

Positions

Because of overlap with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. The revised EU Tobacco Products Directive came into effect in May 2016, providing stricter regulations for e-cigarettes. In February 2010 the US District Court ruled against the FDA's seizure of E-Cigarettes as a "drug-device" and in December 2010 the US Court of Appeals confirmed them to be tobacco products which were by then subject to regulation under the 2009 FSPTC Act. In August 2016, the US FDA extended its regulatory power to include e-cigarettes, cigars, and "all other tobacco products". Large tobacco companies have greatly increased their marketing efforts.

The scientific community in US and Europe are primarily concerned with their possible effect on public health. There is concern among public health experts that e-cigarettes could renormalize smoking, weaken measures to control tobacco, and serve as a gateway for smoking among young people. The public health community is divided over whether to support e-cigarettes, because their safety and efficacy for quitting smoking is unclear. Many in the public health community acknowledge the potential for their quitting smoking and decreasing harm benefits, but there remains a concern over their long-term safety and potential for a new era of users to get addicted to nicotine and then tobacco. There is concern among tobacco control academics and advocates that prevalent universal vaping "will bring its own distinct but as yet unknown health risks in the same way tobacco smoking did, as a result of chronic exposure", among other things.

Medical organizations differ in their views about the health implications of vaping. There is general agreement that e-cigarettes expose users to fewer toxicants than tobacco cigarettes. Some healthcare groups and policy makers have hesitated to recommend e-cigarettes for quitting smoking, because of limited evidence of effectiveness and safety. Some have advocated bans on e-cigarette sales and others have suggested that e-cigarettes may be regulated as tobacco products but with less nicotine content or be regulated as a medicinal product.

A 2019 World Health Organization (WHO) report found that the scientific evidence "does not support the tobacco industry's claim that these products are less harmful relative to conventional tobacco products" and that there is insufficient evidence to support vaping as a smoking cessation tool. Healthcare organizations in the UK (including the Royal College of Physicians and Public Health England) have encouraged smokers to switch to e-cigarettes or other nicotine replacements if they cannot quit, as this would potentially save millions of lives. The American Cancer Society, American Heart Association, and the surgeon general of the United States have cautioned that accumulating evidence indicates e-cigarettes may have negative effects on the heart and lungs and should not be used to quit smoking without sufficient evidence that they are safe and effective.

In 2016, the US Food and Drug Administration (US FDA) stated that "Although ENDS may potentially provide cessation benefits to individual smokers, no ENDS have been approved as effective cessation aids." In 2019 the European Respiratory Society stated that "The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term" and that "he tobacco harm reduction strategy is based on well-meaning but incorrect or undocumented claims or assumptions." Following hundreds of possible cases of severe lung illness and five confirmed deaths associated with vaping in the US, the Centers for Disease Control and Prevention stated on 6 September 2019 that people should consider not using vaping products while their investigation is ongoing.

History

It is commonly stated that the modern e-cigarette was invented in 2003 by Chinese pharmacist Hon Lik, but tobacco companies had been developing nicotine aerosol generation devices since as early as 1963.

Early prototypes and barriers to entry: 1920s–1990s

In 1927, Joseph Robinson applied for a patent for an electronic vaporizer to be used with medicinal compounds. The patent was approved in 1930 but the device was never marketed. In 1930, the United States Patent and Trademark Office reported a patent stating, "for holding medicinal compounds which are electrically or otherwise heated to produce vapors for inhalation." In 1934 and 1936, further similar patents were applied for.

The earliest e-cigarette can be traced to American Herbert A. Gilbert. In 1963, Gilbert applied for a patent for "a smokeless non-tobacco cigarette" that involved "replacing burning tobacco and paper with heated, moist, flavored air". This device produced flavored steam without nicotine. The patent was granted in 1965. Gilbert's invention was ahead of its time. However, it received little attention and was never commercialized because smoking was still fashionable at that time. Gilbert said in 2013 that today's electric cigarettes follow the basic design set forth in his original patent.

The Favor cigarette, introduced in 1986 by public company Advanced Tobacco Products, was another early noncombustible product promoted as an alternative nicotine-containing tobacco product. Favor was conceptualized by Phil Ray, one of the founders of Datapoint Corporation and inventors of the microprocessor. Development started in 1979 by Phil Ray and Norman Jacobson. Favor was a "plastic, smoke-free product shaped and colored like a conventional cigarette that contained a filter paper soaked with liquid nicotine so users could draw a small dose by inhaling. There was no electricity, combustion, or smoke; it delivered only nicotine."

Favor cigarettes were sold in California and several Southwestern states, marketed as "an alternative to smokers, and only to smokers, to use where smoking is unacceptable or prohibited." In 1987, the FDA exercised jurisdiction over products analogous to E-Cigarettes. Advanced Tobacco Products never challenged the Warning Letter and ceased all distribution of Favor. Ray's wife Brenda Coffee coined the term vaping. Philip Morris' division NuMark, launched in 2013 the MarkTen e-cigarette that Philip Morris had been working on since 1990.

Modern electronic cigarette: 2000s

Despite these earlier efforts, Hon Lik, a Chinese pharmacist and inventor, who worked as a research pharmacist for a company producing ginseng products, is frequently credited with the invention of the modern e-cigarette. Hon quit smoking after his father, also a heavy smoker, died of lung cancer. In 2001, he thought of using a high frequency, piezoelectric ultrasound-emitting element to vaporize a pressurized jet of liquid containing nicotine. This design creates a smoke-like vapor. Hon said that using resistance heating obtained better results and the difficulty was to scale down the device to a small enough size. Hon's invention was intended to be an alternative to smoking. Hon Lik sees the e-cigarette as comparable to the "digital camera taking over from the analogue camera." Ultimately, Hon Lik did not quit smoking. He is now a dual user, both smoking and vaping.

Hon Lik registered a patent for the modern e-cigarette design in 2003. Hon is credited with developing the first commercially successful electronic cigarette. The e-cigarette was first introduced to the Chinese domestic market in 2004. Many versions made their way to the US, sold mostly over the Internet by small marketing firms. E-cigarettes entered the European market and the US market in 2006 and 2007. The company that Hon worked for, Golden Dragon Holdings, registered an international patent in November 2007. The company changed its name to Ruyan (如烟, literally "like smoke") later the same month, and started exporting its products.

Many US and Chinese e-cigarette makers copied his designs illegally, so Hon has not received much financial reward for his invention (although some US manufacturers have compensated him through out-of-court settlements). Ruyan later changed its company name to Dragonite International Limited. As of 2014, most e-cigarettes used a battery-powered heating element rather than the earlier ultrasonic technology design.

Initially, their performance did not meet the expectations of users. The e-cigarette continued to evolve from the first-generation three-part device. In 2007, British entrepreneurs Umer and Tariq Sheikh invented the cartomizer. This is a mechanism that integrates the heating coil into the liquid chamber. They launched this new device in the UK in 2008 under their Gamucci brand and the design is now widely adopted by most "cigalike" brands. Other users tinkered with various parts to produce more satisfactory homemade devices, and the hobby of "modding" was born. The first mod to replace the e-cigarette's case to accommodate a longer-lasting battery, dubbed the "screwdriver", was developed by Ted and Matt Rogers in 2008. Other enthusiasts built their own mods to improve functionality or aesthetics. When pictures of mods appeared at online vaping forums many people wanted them, so some mod makers produced more for sale.

In 2008, a consumer created an e-cigarette called the screwdriver. The device generated a lot of interest back then, as it let the user to vape for hours at one time. The invention led to demand for customizable e-cigarettes, prompting manufacturers to produce devices with interchangeable components that could be selected by the user. In 2009, Joyetech developed the eGo series which offered the power of the screwdriver model and a user-activated switch to a wide market. The clearomizer was invented in 2009. Originating from the cartomizer design, it contained the wicking material, an e-liquid chamber, and an atomizer coil within a single clear component. The clearomizer allows the user to monitor the liquid level in the device. Soon after the clearomizer reached the market, replaceable atomizer coils and variable voltage batteries were introduced. Clearomizers and eGo batteries became the best-selling customizable e-cigarette components in early 2012.

International growth: 2010s – present

International tobacco companies dismissed e-cigarettes as a fad at first. However, recognizing the development of a potential new market sector that could render traditional tobacco products obsolete, they began to produce and market their own brands of e-cigarettes and acquire existing e-cigarette companies. They bought the largest e-cigarette companies. blu eCigs, a prominent US e-cigarette manufacturer, was acquired by Lorillard Inc. for $135 million in April 2012.

British American Tobacco was the first tobacco business to sell e-cigarettes in the UK. They launched the e-cigarette Vype in July 2013, while Imperial Tobacco's Fontem Ventures acquired the intellectual property owned by Hon Lik through Dragonite International Limited for $US 75 million in 2013 and launched Puritane in partnership with Boots UK. On 1 October 2013 Lorillard Inc. acquired another e-cigarette company, this time the UK based company SKYCIG. SKY was rebranded as blu.

On 3 February 2014, Altria Group, Inc. acquired popular e-cigarette brand Green Smoke for $110 million. The deal was finalized in April 2014 for $110 million with $20 million in incentive payments. Altria also markets its own e-cigarette, the MarkTen, while Reynolds American has entered the sector with its Vuse product. Philip Morris, the world's largest tobacco company, purchased UK's Nicocigs in June 2014. On 30 April 2015, Japan Tobacco bought the US Logic e-cigarette brand. Japan Tobacco also bought the UK E-Lites brand in June 2014. On 15 July 2014, Lorillard sold blu to Imperial Tobacco as part of a deal for $7.1 billion. As of 2018, 95% of e-cigarettes were made in China.

In the UK, where most vaping uses refillable sets and e-liquid, there is now support from the National Health Service, and other medical bodies now embrace the use of e-cigarettes as a viable way to quit smoking. This has contributed to record numbers of people vaping, with estimated 3.6 million in 2019, 3.2 million in 2020, rising to 3.6 million in 2021. Current vapers being 2.2 million as of 2024.

Society and culture

Consumers have shown passionate support for e-cigarettes that other nicotine replacement products did not receive. They have a mass appeal that could challenge combustible tobacco's market position.

By 2013, a subculture had emerged calling itself "the vaping community". Members often see e-cigarettes as a safer alternative to smoking, and some view it as a hobby. The online forum E-Cig-Reviews.com was one of the first major communities. It and other online forums, such as UKVaper.org, were where the hobby of modding started. There are also groups on Facebook and Reddit. Online forums based around modding have grown in the vaping community.

Vapers embrace activities associated with e-cigarettes and sometimes evangelise for them. E-cigarette companies have a substantial online presence, and there are many individual vapers who blog and tweet about e-cigarette related products. A 2014 Postgraduate Medical Journal editorial said vapers "also engage in grossly offensive online attacks on anyone who has the temerity to suggest that ENDS are anything other than an innovation that can save thousands of lives with no risks".

Contempt for Big Tobacco is part of vaping culture. A 2014 review stated that tobacco and e-cigarette companies interact with consumers for their policy agenda. The companies use websites, social media, and marketing to get consumers involved in opposing bills that include e-cigarettes in smoke-free laws. This is similar to tobacco industry activity going back to the 1980s. These approaches were used in Europe to minimize the EU Tobacco Products Directive in October 2013. Grassroots lobbying also influenced the Tobacco Products Directive decision. Tobacco companies have worked with organizations conceived to promote e-cigarette use, and these organizations have worked to hamper legislation intended at restricting e-cigarette use.

Large gatherings of vapers, called vape meets, take place around the US. They focus on e-cigarette devices, accessories, and the lifestyle that accompanies them. Vapefest, which started in 2010, is an annual show hosted by different cities. People attending these meetings are usually enthusiasts that use specialized, community-made products not found in convenience stores or gas stations. These products are mostly available online or in dedicated "vape" storefronts where mainstream e-cigarettes brands from the tobacco industry and larger e-cig manufacturers are not as popular. Some vape shops have a vape bar where patrons can test out different e-liquids and socialize. The Electronic Cigarette Convention in North America which started in 2013, is an annual show where companies and consumers meet up.

A subclass of vapers configure their atomizers to produce large amounts of vapor by using low-resistance heating coils. This practice is called "cloud-chasing". By using a coil with very low resistance, the batteries are stressed to a potentially unsafe extent. This could present a risk of dangerous battery failures. As vaping comes under increased scrutiny, some members of the vaping community have voiced their concerns about cloud-chasing, stating the practice gives vapers a bad reputation when doing it in public. The Oxford Dictionaries' word of the year for 2014 was "vape".

Regulation

Regulation of e-cigarettes varies across countries and states, ranging from no regulation to banning them entirely. For instance, e-cigarettes containing nicotine are illegal in Japan, forcing the market to use heated tobacco products for cigarette alternatives. Others have introduced strict restrictions and some have licensed devices as medicines such as in the UK. However, as of February 2018, there is no e-cigarette device that has been given a medical license that is commercially sold or available by prescription in the UK. As of 2015, around two thirds of major nations have regulated e-cigarettes in some way.

Because of the potential relationship with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. The companies that make e-cigarettes have been pushing for laws that support their interests. In 2016 the US Department of Transportation banned the use of e-cigarettes on commercial flights. This regulation applies to all flights to and from the US. In 2018, the Royal College of Physicians asked that a balance is found in regulations over e-cigarettes that ensure product safety while encouraging smokers to use them instead of tobacco, as well as keep an eye on any effects contrary to the control agencies for tobacco.

The legal status of e-cigarettes is currently pending in many countries. Many countries such as Brazil, Singapore, Uruguay, and India have banned e-cigarettes. Canada-wide in 2014, they were technically illegal to sell, as no nicotine-containing e-cigarettes are not regulated by Health Canada, but this is generally unenforced and they are commonly available for sale Canada-wide. In 2016, Health Canada announced plans to regulate vaping products. In the US and the UK, the use and sale to adults of e-cigarettes are legal. The revised EU Tobacco Products Directive came into effect in May 2016, providing stricter regulations for e-cigarettes. It limits e-cigarette advertising in print, on television and radio, along with reducing the level of nicotine in liquids and reducing the flavors used. It does not ban vaping in public places. It requires the purchaser for e-cigarettes to be at least 18 and does not permit buying them for anyone less than 18 years of age. The updated Tobacco Products Directive has been disputed by tobacco lobbyists whose businesses could be impacted by these revisions.

As of 8 August 2016, the US FDA extended its regulatory power to include e-cigarettes, e-liquid and all related products. Under this ruling the FDA will evaluate certain issues, including ingredients, product features and health risks, as well their appeal to minors and non-users. The FDA rule also bans access to minors. A photo ID is now required to buy e-cigarettes, and their sale in all-ages vending machines is not permitted in the US. As of August 2017, regulatory compliance deadlines relating to premarket review requirements for most e-cigarette and e-liquid products have been extended from November 2017 to 8 August 2022, which attracted a lawsuit filed by the American Heart Association, American Academy of Pediatrics, the Campaign for Tobacco-Free Kids, and other plaintiffs.

In May 2016, the US FDA used its authority under the Family Smoking Prevention and Tobacco Control Act to deem e-cigarette devices and e-liquids to be tobacco products, which meant it intended to regulate the marketing, labelling, and manufacture of devices and liquids; vape shops that mix e-liquids or make or modify devices were considered manufacturing sites that needed to register with US FDA and comply with good manufacturing practice regulation. E-cigarette and tobacco companies have recruited lobbyists in an effort to prevent the US FDA from evaluating e-cigarette products or banning existing products already on the market.

In February 2014, the European Parliament passed regulations requiring standardization and quality control for liquids and vaporizers, disclosure of ingredients in liquids, and child-proofing and tamper-proofing for liquid packaging. In April 2014 the US FDA published proposed regulations for e-cigarettes. In the US some states tax e-cigarettes as tobacco products, and some state and regional governments have broadened their indoor smoking bans to include e-cigarettes. As of April 2017, 12 US states and 615 localities had prohibited the use of e-cigarettes in venues in which traditional cigarette smoking was prohibited. In 2015, at least 48 states and 2 territories had banned e-cigarette sales to minors.

In November 2020, the New Zealand government passed a vaping regulation that requires vape stores to register as specialist vape retailers before they can sell e-cigarettes, the wider range of flavoured e-liquids, and other related vaping products. Vaping products are required to be notified by the government before they can be sold to ensure that the products are following safety requirements and ingredients in liquids do not contain prohibited substances.

E-cigarettes containing nicotine have been listed as drug delivery devices in a number of countries, and the marketing of such products has been restricted or put on hold until safety and efficacy clinical trials are conclusive. Since they do not contain tobacco, television advertising in the US is not restricted. Some countries have regulated e-cigarettes as a medical product even though they have not approved them as a smoking cessation aid. A 2014 review stated the emerging phenomenon of e-cigarettes has raised concerns in the health community, governments, and the general public and recommended that e-cigarettes should be regulated to protect consumers. It added, "heavy regulation by restricting access to e-cigarettes would just encourage continuing use of much unhealthier tobacco smoking." A 2014 review said regulation of the e-cigarette should be considered on the basis of reported adverse health effects.

Criticism of vaping bans

Critics of vaping bans state that vaping is a much safer alternative to smoking tobacco products and that vaping bans incentivize people to return to smoking cigarettes. For example, critics cite the British Journal of Family Medicine in August 2015 which stated, "E-cigarettes are 95% safer than traditional smoking." Additionally, San Francisco's chief economist, Ted Egan, when discussing the San Francisco vaping ban stated the city's ban on e-cigarette sales will increase smoking as vapers switch to combustible cigarettes. Critics of smoking bans stress the absurdity of criminalizing the sale of a safer alternative to tobacco while tobacco continues to be legal. Prominent proponents of smoking bans are not in favor of criminalizing tobacco either, but rather allowing consumers to have the choice to choose whatever products they desire.

In 2022, after two years of review, the Food and Drug Administration (FDA) denied Juul's application to keep its tobacco and menthol flavored vaping products on the market. Critics of this denial note that research published in Nicotine and Tobacco Research found that smokers who transitioned to Juuls in North America were significantly more likely to switch to vaping than those in the United Kingdom who only had access to lower-strength nicotine products. This happens as the Biden administration seeks to mandate low-nicotine cigarettes which, critics note, is not what makes cigarettes dangerous. They also note that vaping does not contain many of the components that make smoking dangerous such as the combustion process and certain chemicals that are present in cigarettes that are not present in vape products.

Product liability

Multiple reports from the U.S. Fire Administration conclude that electronic cigarettes have been combusting and injuring people and surrounding areas. The composition of a cigarette is the cause of this, as the cartridges that are meant to contain the liquid mixture are in such close proximity to the battery. A research report by the U.S. Fire Administration supports this, stating that, "Unlike mobile phones, some e-cigarette lithium-ion batteries within e-cigarettes offer no protection to stop the coil overheating".

In 2015, the U.S. Fire Administration noted in their report that electronic cigarettes are not created by Big Tobacco or other tobacco companies, but by independent factories that have little quality control. Because of this low quality control when made, electronic cigarettes have led to incidents in which people are hurt, or in which the surrounding area is damaged.

Marketing

They are marketed to men, women, and children as being safer than traditional cigarettes. They are also marketed to non-smokers. E-cigarette marketing is common. There are growing concerns that e-cigarette advertising campaigns unjustifiably focus on young adults, adolescents, and women. Large tobacco companies have greatly increased their marketing efforts. This marketing trend may expand the use of e-cigarettes and contribute to re-glamorizing smoking. Some companies may use e-cigarette advertising to advocate smoking, deliberately, or inadvertently, is an area of concern. A 2014 review said, "the e-cigarette companies have been rapidly expanding using aggressive marketing messages similar to those used to promote cigarettes in the 1950s and 1960s."

E-cigarette companies are using methods that were once used by the tobacco industry to persuade young people to start using cigarettes. E-cigarettes are promoted to a certain extent to forge a vaping culture that entices non-smokers. Themes in e-cigarette marketing, including sexual content and customer satisfaction, are parallel to themes and techniques that are appealing to young people and young adults in traditional cigarette advertising and promotion. A 2017 review found "The tobacco industry sees a future where ENDS accompany and perpetuate, rather than supplant, tobacco use, especially targeting the youth." E-cigarettes and nicotine are regularly promoted as safe and even healthy in the media and on brand websites, which is an area of concern.

While advertising of tobacco products is banned in most countries, television and radio e-cigarette advertising in several countries may be indirectly encouraging traditional cigarette use. E-cigarette advertisements are also in magazines, newspapers, online, and in retail stores. Between 2010 and 2014, e-cigarettes were second only to cigarettes as the top advertised product in magazines. As cigarette companies have acquired the largest e-cigarette brands, they currently benefit from a dual market of smokers and e-cigarette users while simultaneously presenting themselves as agents of harm reduction. This raises concerns about the appropriateness of endorsing a product that directly profits the tobacco industry. There is no evidence that the cigarette brands are selling e-cigarettes as part of a plan to phase out traditional cigarettes, despite some stating to want to cooperate in "harm reduction". E-cigarette advertising for using e-cigarettes as a quitting tool have been seen in the US, UK, and China, which have not been supported by regulatory bodies.

In the US, six large e-cigarette businesses spent $59.3 million on promoting e-cigarettes in 2013. In the US and Canada, over $2 million is spent yearly on promoting e-cigarettes online. E-cigarette websites often made unscientific health statements in 2012. The ease to get past the age verification system at e-cigarette company websites allows underage individuals to access and be exposed to marketing. Around half of e-cigarette company websites have a minimum age notice that prohibited underage individuals from entering.

Celebrity endorsements are used to encourage e-cigarette use. A 2012 national US television advertising campaign for e-cigarettes starred Stephen Dorff exhaling a "thick flume" of what the advertisement describes as "vapor, not tobacco smoke", exhorting smokers with the message "We are all adults here, it's time to take our freedom back." Opponents of the tobacco industry state that the Blu advertisement, in a context of longstanding prohibition of tobacco advertising on television, seems to have resorted to advertising tactics that got former generations of people in the US addicted to traditional cigarettes. Cynthia Hallett of Americans for Non-Smokers' Rights described the US advertising campaign as attempting to "re-establish a norm that smoking is okay, that smoking is glamorous and acceptable".

University of Pennsylvania communications professor Joseph Cappella stated that the setting of the advertisement near an ocean was meant to suggest an association of clean air with the nicotine product. In 2012 and 2013, e-cigarette companies advertised to a large television audience in the US which included 24 million young people. The channels to which e-cigarette advertising reached the largest numbers of young people (ages 12–17) were AMC, Country Music Television, Comedy Central, WGN America, TV Land, and VH1.

Since at least 2007, e-cigarettes have been heavily promoted across media outlets globally. They are vigorously advertised, mostly through the Internet, as a safe substitute to traditional cigarettes, among other things. E-cigarette companies promote their e-cigarette products on Facebook, Instagram, YouTube, and Twitter. They are promoted on YouTube by movies with sexual material and music icons, who encourage minors to "take their freedom back." They have partnered with a number of sports and music icons to promote their products. Tobacco companies intensely market e-cigarettes to young people, with industry strategies including cartoon characters and candy flavors. Fruit flavored e-liquid is the most commonly marketed e-liquid flavor on social media.

E-cigarette companies commonly promote that their products contain only water, nicotine, glycerin, propylene glycol, and flavoring but this assertion is misleading as researchers have found differing amounts of heavy metals in the vapor, including chromium, nickel, tin, silver, cadmium, mercury, and aluminum. The widespread assertion that e-cigarettes emit "only water vapor" is not true because the evidence demonstrates e-cigarette vapor contains possibly harmful chemicals such as nicotine, carbonyls, metals, and volatile organic compounds, in addition to particulate matter. Massive advertising included the assertion that they would present little risk to non-users. However, "disadvantages and side effects have been reported in many articles, and the unfavorable effects of its secondhand vapor have been demonstrated in many studies", and evidence indicates that use of e-cigarettes degrades indoor air quality.

Many e-cigarette companies market their products as a smoking cessation aid without evidence of effectiveness. E-cigarette marketing has been found to make unsubstantiated health statements (e.g., that they help one quit smoking) including statements about improving psychiatric symptoms, which may be particularly appealing to smokers with mental illness. E-cigarette marketing advocate weight control and emphasize use of nicotine with many flavors. These marketing angles could particularly entice overweight people, young people, and vulnerable groups. Some e-cigarette companies state that their products are green without supporting evidence which may be purely to increase their sales.

Economics

The number of e-cigarettes sold increased every year from 2003 to 2014. In 2015 a slowdown in the growth in usage occurred in the US. As of January 2018, the growth in usage in the UK has slowed down since 2013. As of 2014, there were at least 466 e-cigarette brands. Worldwide e-cigarette sales in 2014 were around US$7 billion. Worldwide e-cigarette sales in 2019 were about $19.3 billion. E-cigarette sales could exceed traditional cigarette sales by 2023. Approximately 30–50% of total e-cigarettes sales are handled on the internet. Established tobacco companies have a significant share of the e-cigarette market.

As of 2018, 95% of e-cigarette devices were made in China, mainly in Shenzhen. Chinese companies' market share of e-liquid is low. In 2014, online and offline sales started to increase. Since combustible cigarettes are relatively inexpensive in China a lower price may not be a large factor in marketing vaping products over there.

In 2015, 80% of all e-cigarette sales in convenience stores in the US were products made by tobacco companies. According to Nielsen Holdings, convenience store e-cigarette sales in the US went down for the first time during the four-week period ending on 10 May 2014. Wells Fargo analyst Bonnie Herzog attributes this decline to a shift in consumers' behavior, buying more specialized devices or what she calls "vapors-tanks-mods (VTMs)" that are not tracked by Nielsen. Wells Fargo estimated that VTMs accounted for 57% of the 3.5 billion dollar market in the US for vapor products in 2015.

In 2014, dollar sales of customizable e-cigarettes and e-liquid surpassed sales of cigalikes in the US, even though, overall, customizables are a less expensive vaping option. In 2014, the Smoke-Free Alternatives Trade Association estimated that there were 35,000 vape shops in the US, more than triple the number a year earlier. However the 2015 slowdown in market growth affected VTMs as well.

Large tobacco retailers are leading the cigalike market. "We saw the market's sudden recognition that the cigarette industry seems to be in serious trouble, disrupted by the rise of vaping," Mad Money's Jim Cramer stated April 2018. "Over the course of three short days, the tobacco stocks were bent, they were spindled and they were mutilated by the realization that electronic cigarettes have become a serious threat to the old-school cigarette makers," he added. In 2019, a vaping industry organization released a report stating that a possible US ban on e-cigarettes flavors can potentially effect greater than 150,000 jobs around the US.

The leading seller in the e-cigarette market in the US is the Juul e-cigarette, which was introduced in June 2015. As of August 2018, Juul accounts for over 72% of the US e-cigarette market monitored by Nielsen, and its closest competitor—RJ Reynolds' Vuse—makes up less than 10% of the market. Juul rose to popularity quickly, growing by 700% in 2016 alone. On 17 July 2018 Reynolds announced it will debut in August 2018 a pod mod type device similar Juul. The popularity of the Juul pod system has led to a flood of other pod devices hitting the market.

In Canada, e-cigarettes had an estimated value of 140 million CAD in 2015. There are numerous e-cigarette retail shops in Canada. A 2014 audit of retailers in four Canadian cities found that 94% of grocery stores, convenience stores, and tobacconist shops which sold e-cigarettes sold nicotine-free varieties only, while all vape shops stocked at least one nicotine-containing product.

By 2015, the e-cigarette market had only reached a twentieth of the size of the tobacco market in the UK. In the UK in 2015 the "most prominent brands of cigalikes" were owned by tobacco companies, however, with the exception of one model, all the tank types came from "non-tobacco industry companies". Yet some tobacco industry products, while using prefilled cartridges, resemble tank models.

France's e-cigarette market was estimated by Groupe Xerfi to be €130 million in 2015. Additionally, France's e-liquid market was estimated at €265 million. In December 2015, there were 2,400 vape shops in France, 400 fewer than in March of the same year. Industry organization Fivape said the reduction was due to consolidation, not to reduced demand.

In Vietnam, the e-cigarette market is growing rapidly, with the use rate increasing 18 times from 2015 to 2020. The use rate of e-cigarettes in adolescents aged 13–15 is 3.5%, up 1.6% from 2019. According to estimates by the World Health Organization (WHO), the global economic losses caused by tobacco each year are $1.4 trillion. Economic losses caused by tobacco are estimated to account for 1% of GDP. The Vietnamese government is making efforts to control the e-cigarette market. However, here are still many challenges to be addressed, such as consumer's lack of understanding of the harm of e-cigarettes, unclear legal regulations, and fierce competition from imported e-cigarette products.

Environmental impact

Compared to traditional cigarettes, reusable e-cigarettes do not create waste and potential litter from every use in the form of discarded cigarette butts. Traditional cigarettes tend to end up in the ocean where they cause pollution, though once discarded they undergo biodegradation and photodegradation. Although some brands have begun recycling services for their e-cigarette cartridges and batteries, the prevalence of recycling is unknown.

E-cigarettes that are not reusable contribute to the problem of electronic waste, which can create a hazard for people and other organisms. If improperly disposed of, they can release heavy metals, nicotine, and other chemicals from batteries and unused e-liquid. A July 2018–April 2019 garbology study found e-cigarette products composed 19% of the waste from all traditional and electronic tobacco and cannabis products collected at 12 public high schools in Northern California.

Councils in England and Wales are pushing for a 2024 ban on single-use vapes due to environmental and health risks, as 1.3 million are thrown away weekly. Recycling challenges, waste issues, and fire hazards are cited. Concerns about youth vaping are also raised. The UK Vaping Industry Association defends disposables as quitting aids but warns of potential black market products if banned.

Related technologies

Other devices to deliver inhaled nicotine have been developed. They aim to mimic the ritual and behavioral aspects of traditional cigarettes.

British American Tobacco, through their subsidiary Nicoventures, licensed a nicotine delivery system based on existing asthma inhaler technology from UK-based healthcare company Kind Consumer. In September 2014 a product based on this named Voke obtained approval from the United Kingdom's Medicines and Healthcare Products Regulatory Agency.

In 2011, Philip Morris International bought the rights to a nicotine pyruvate technology developed by Jed Rose at Duke University. The technology is based on the chemical reaction between pyruvic acid and nicotine, which produces an inhalable nicotine pyruvate vapor. Philip Morris Products S.A. created a different kind e-cigarette named P3L. The device is supplied with a cartridge that contains nicotine and lactic acid in different cavities. When turned on and heated, the nicotine salt called nicotine lactate forms an aerosol.

The IQOS is a heated tobacco product marketed by Philip Morris International. It heats tobacco at a lower temperature than traditional cigarettes. The tobacco sticks reach a temperature up to 350 °C. It sold first in Japan since November 2014. In December 2016, the United Tobacco Vapor Group's (UTVG) stated that they have been given a patent for their vaporizing component system. qmos from UTVG does not contain a wick or sponge and the number of components is 5 compared to 20 for traditional e-cigarettes.

Pax Labs has developed vaporizers that heats the leaves of tobacco to deliver nicotine in a vapor. In June 2015, they introduced Juul, a type of e-cigarette which delivers 10 times as much nicotine as other e-cigarettes, equivalent to an actual cigarette puff. Juul was spun off from Pax Labs in June 2017 and is now available by the independent company Juul Labs. The eTron 3T from Vapor Tobacco Manufacturing, launched in December 2014, employs a patented, aqueous system whereby the tobacco is extracted into water. The e-liquid contains organic tobacco, organic glycerin, and water.

In December 2013, Japan Tobacco launched Ploom in Japan. In January 2016, they launched Ploom TECH that produces a vapor from a heated liquid that moves through a capsule of granulated tobacco leaves. In 2016, British American Tobacco (BAT) released its own version of the heat but not burn technology called glo in Japan and Switzerland. It uses tobacco sticks rather than nicotine liquid, and does not directly heat or burn tobacco. Heated tobacco products were first introduced in 1988, but were not a commercial success.

BLOW started selling e-hookahs, an electronic version of the hookah in 2014. The handle of each hose for the e-hookah contains a heating element and a liquid, which produces vapor. Gopal Bhatnagar, based in Toronto, Canada, invented a 3D printed adapter to turn a traditional hookah into an e-hookah. It is used instead of the ceramic bowl that contains shisha tobacco. Rather than the tobacco, users can insert e-cigarettes.

Cannabis vaping

Some vape pens, generally not referred to as "e-cigarettes", contain cannabis derivatives instead of nicotine and tobacco derivatives. Some cannabis pens, known as "dab pens", contain cannabis extracted using butane as solvent ("butane hash oil"). Other vaporizers contain e-liquid made with pure THC, and they generally resemble conventional e-cigarettes. A 2020 study shows that one third of teenagers engaged in conventional, tobacco vaping also engage in THC vaping.

KanaVape is an e-cigarette containing cannabidiol (CBD) and no THC. Several companies including Canada's Eagle Energy Vapor are selling caffeine-based e-cigarettes instead of containing nicotine.

See also

• Vaping cessation

Notes

1. Also known as an e-cig, vaporizer, vape pen, hookah pen, e-pipe, or, formally, electronic nicotine delivery system (ENDS).
2. A 2014 review found "In addition to the uniqueness of the liquid compositions in each brand, inconsistency of both the device performance properties and the data collection methodologies used by researchers contribute to the observed variation in constituent levels and to the range of particle size distributions among products."
3. "Most ENDS consist of a rechargeable, battery-operated heating element and a replaceable or refillable cartridge for the e-liquid. An atomizer heats the liquid in the cartridge to convert it into an aerosol, which is then inhaled by the user. Most of these products are rechargeable, but some are disposable."
4. "Once again, there is a strong potential for confounding, such that comparisons of dual users with smokers who do not use e-cigarettes will not yield meaningful causal estimates"
5. A 2019 review concluded that, "no long term vaping toxicological/safety studies have been done in humans; without these data, saying with certainty that e-cigarettes are safer than combustible cigarettes is impossible."
6. Two of the authors of this study received funding from Pfizer, which manufactures nicotine replacement therapy products.
7. Since 2016 the US Food and Drug Administration (US FDA) regulated e-cigarettes under the classification of tobacco products and labeled them as electronic nicotine delivery systems. A 2018 report commissioned by the US FDA decided to use the term e-cigarettes, indicating that for some use e-liquids containing no nicotine.
8. "The ACS does not recommend the use of e-cigarettes as a cessation method. No e-cigarette has been approved by the Food and Drug Administration (FDA) as a safe and effective cessation product. The long-term risks of exclusive use of e-cigarettes are not fully known but evidence is accumulating that e-cigarette use has negative effects on the cardiovascular system and lungs. Without immediate measures to stop epidemic use of these products, the long-term adverse health effects will increase."
9. "Companies should not be able to claim that e-cigarettes are a cessation aid unless they are approved by the FDA for that purpose...There is not yet enough evidence for clinicians to counsel their patients who are using combustible tobacco products to use e-cigarettes as a primary cessation aid. The association will continue to monitor the evidence concerning e-cigarettes as cessation devices to determine whether they might be integrated into comprehensive cessation strategies. For patients with existing cardiovascular disease and stroke, or at risk of a cardiovascular disease event, intensive cessation counseling should be offered as soon as possible."
10. Alteria no longer sells e-cigarettes.

References

1. ^ "Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS)". United States Food and Drug Administration. 14 February 2020. This article incorporates text from this source, which is in the public domain.
2. ^ Cheng, T. (2014). "Chemical evaluation of electronic cigarettes". Tobacco Control. 23 (Supplement 2): ii11–ii17. doi:10.1136/tobaccocontrol-2013-051482. ISSN 0964-4563. PMC 3995255. PMID 24732157.
3. ^ Orellana-Barrios, Menfil A.; Payne, Drew; Mulkey, Zachary; Nugent, Kenneth (2015). "Electronic cigarettes-a narrative review for clinicians". The American Journal of Medicine. 128 (7): 674–81. doi:10.1016/j.amjmed.2015.01.033. ISSN 0002-9343. PMID 25731134.
4. ^ Weaver, Michael; Breland, Alison; Spindle, Tory; Eissenberg, Thomas (2014). "Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 234–240. doi:10.1097/ADM.0000000000000043. ISSN 1932-0620. PMC 4123220. PMID 25089953.
5. David, Grégory; Parmentier, Evelyne A.; Taurino, Irene; Signorell, Ruth (December 2020). "Tracing the composition of single e-cigarette aerosol droplets in situ by laser-trapping and Raman scattering". Scientific Reports. 10 (1): 7929. Bibcode:2020NatSR..10.7929D. doi:10.1038/s41598-020-64886-5. PMC 7220912. PMID 32404884.
6. ^ Rahman, Muhammad; Hann, Nicholas; Wilson, Andrew; Worrall-Carter, Linda (2014). "Electronic cigarettes: patterns of use, health effects, use in smoking cessation and regulatory issues". Tobacco Induced Diseases. 12 (1): 21. doi:10.1186/1617-9625-12-21. PMC 4350653. PMID 25745382.
7. ^ Pepper, J. K.; Brewer, N. T. (2013). "Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review". Tobacco Control. 23 (5): 375–384. doi:10.1136/tobaccocontrol-2013-051122. ISSN 0964-4563. PMC 4520227. PMID 24259045.
8. ^ Drope, Jeffrey; Cahn, Zachary; Kennedy, Rosemary; Liber, Alex C.; Stoklosa, Michal; Henson, Rosemarie; Douglas, Clifford E.; Drope, Jacqui (November 2017). "Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine". CA: A Cancer Journal for Clinicians. 67 (6): 449–471. doi:10.3322/caac.21413. ISSN 0007-9235. PMID 28961314. S2CID 32928770.
9. "Policy on Electronic Nicotine Delivery Systems (ENDS)" (PDF). American Academy of Pediatrics. 2020. Retrieved 13 November 2022.
10. "Position Statements on e-cigarettes". American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). 21 April 2021. Archived from the original on 13 November 2022. Retrieved 13 November 2022.
11. Schraufnagel, Dean E.; Blasi, Francesco; Drummond, M. Bradley; Lam, David C. L.; Latif, Ehsan; Rosen, Mark J.; Sansores, Raul; Van Zyl-Smit, Richard (15 September 2014). "Electronic Cigarettes. A Position Statement of the Forum of International Respiratory Societies". American Journal of Respiratory and Critical Care Medicine. 190 (6): 611–618. doi:10.1164/rccm.201407-1198PP. ISSN 1073-449X. PMID 25006874. S2CID 43763340. Retrieved 13 November 2022.
12. Miyasato, K. (March 2013). "". Nihon Rinsho. Japanese Journal of Clinical Medicine (in Japanese). 71 (3): 477–481. PMID 23631239.
13. Marques, Patrice; Piqueras, Laura; Sanz, Maria-Jesus (December 2021). "An updated overview of e-cigarette impact on human health". Respiratory Research. 22 (1): 151. doi:10.1186/s12931-021-01737-5. PMC 8129966. PMID 34006276. S2CID 234753956. the safety of e-cigarette consumption and its potential as a smoking cessation method remain controversial due to limited evidence...the potential long-term effects of e-cigarette consumption have been scarcely investigated.
14. Walley, Susan C.; Wilson, Karen M.; Winickoff, Jonathan P.; Groner, Judith (1 June 2019). "A Public Health Crisis: Electronic Cigarettes, Vape, and JUUL". Pediatrics. 143 (6): e20182741. doi:10.1542/peds.2018-2741. PMID 31122947. S2CID 163165584. Because e-cigarettes have only been marketed for ~10 years... scientific data are limited and will continue to emerge. Because e-cigarette solutions and emissions have been shown to contain nicotine and many of the same harmful toxicants and carcinogens as cigarettes, it is reasonable to assume that there is the potential for similar health effects for e-cigarette use, particularly with emerging data of tobacco toxicant exposure found among e-cigarette users.
15. Kim, Sooyong; Selya, Arielle S (12 June 2020). "The Relationship Between Electronic Cigarette Use and Conventional Cigarette Smoking Is Largely Attributable to Shared Risk Factors". Nicotine & Tobacco Research. 22 (7): 1123–1130. doi:10.1093/ntr/ntz157. PMC 7291806. PMID 31680169. past research remains inconclusive due to heavy confounding between cigarette and e-cigarette use
16. Gotts, Jeffrey E; Jordt, Sven-Eric; McConnell, Rob; Tarran, Robert (30 September 2019). "What are the respiratory effects of e-cigarettes?". BMJ. 366: l5275. doi:10.1136/bmj.l5275. PMC 7850161. PMID 31570493. We reiterate that, to date, no long term vaping toxicological/safety studies have been done in humans; without these data, saying with certainty that e-cigarettes are safer than combustible cigarettes is impossible.
17. Benowitz, Neal L.; Burbank, Andrea D. (August 2016). "Cardiovascular toxicity of nicotine: Implications for electronic cigarette use". Trends in Cardiovascular Medicine. 26 (6): 515–523. doi:10.1016/j.tcm.2016.03.001. PMC 4958544. PMID 27079891. It is difficult to distinguish the independent roles of nicotine vs tobacco combustion products in cigarette smokers because all smokers are exposed to both.
18. ^ Bals, Robert; Boyd, Jeanette; Esposito, Susanna; Foronjy, Robert; Hiemstra, Pieter; Jiménez-Ruiz, Carlos A.; Katsaounou, Paraskevi; Lindberg, Anne; Metz, Carlos; Schober, Wolfgang; Spira, Avrum; Blasi, Francesco (February 2019). "Electronic cigarettes: a task force report from the European Respiratory Society". European Respiratory Journal. 53 (2): 1801151. doi:10.1183/13993003.01151-2018. ISSN 0903-1936. PMID 30464018. S2CID 53711734. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.
19. National Academies of Sciences, Engineering, and Medicine (2018), p. : "Laboratory tests of e-cigarette ingredients, in vitro toxicological tests, and short-term human studies suggest that e-cigarettes are likely to be far less harmful than combustible tobacco cigarettes."
20. Health and Care Excellence, The National Institute for (30 November 2021). "Recommendations on treating tobacco dependence Tobacco: preventing uptake, promoting quitting and treating dependence. Guidance NICE". www.nice.org.uk. Retrieved 13 November 2022. use of e‑cigarettes is likely to be substantially less harmful than smoking
21. ^ Balfour, David J. K.; Benowitz, Neal L.; Colby, Suzanne M.; Hatsukami, Dorothy K.; Lando, Harry A.; Leischow, Scott J.; Lerman, Caryn; Mermelstein, Robin J.; Niaura, Raymond; Perkins, Kenneth A.; Pomerleau, Ovide F.; Rigotti, Nancy A.; Swan, Gary E.; Warner, Kenneth E.; West, Robert (September 2021). "Balancing Consideration of the Risks and Benefits of E-Cigarettes". American Journal of Public Health. 111 (9): 1661–1672. doi:10.2105/AJPH.2021.306416. PMC 8589069. PMID 34410826. Among potentially toxic substances common to both products, cigarette smoke generally contains substantially larger quantities than e-cigarette aerosol. However, e-cigarette aerosol contains some substances not found in cigarette smoke."
22. ^ Lindson, Nicola; Butler, Ailsa R.; McRobbie, Hayden; Bullen, Chris; Hajek, Peter; Begh, Rachna; Theodoulou, Annika; Notley, Caitlin; Rigotti, Nancy A.; Turner, Tari; Livingstone-Banks, Jonathan; Morris, Tom; Hartmann-Boyce, Jamie (8 January 2024). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 1 (1): CD010216. doi:10.1002/14651858.CD010216.pub8. ISSN 1469-493X. PMC 10772980. PMID 38189560.
23. Lindson, N; Butler, AR; McRobbie, H; Bullen, C; Hajek, P; Begh, R; Theodoulou, A; Notley, C; Rigotti, NA; Turner, T; Livingstone-Banks, J; Morris, T; Hartmann-Boyce, J (8 January 2024). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 1 (1): CD010216. doi:10.1002/14651858.CD010216.pub8. PMC 10772980. PMID 38189560. Retrieved 17 April 2024.
24. ^ Carpenter, Matthew J.; Wahlquist, Amy E.; Dahne, Jennifer; Gray, Kevin M.; Cummings, K. Michael; Warren, Graham; Wagener, Theodore L.; Goniewicz, Maciej L.; Smith, Tracy T. (September 2023). ""Effect of unguided e-cigarette provision on uptake, use, and smoking cessation among adults who smoke in the USA: a naturalistic, randomised, controlled clinical trial."". eClinicalMedicine. 63: 102142. doi:10.1016/j.eclinm.2023.102142. PMC 10518503. PMID 37753443.
25. ^ Al-Hamdani, Mohammed; Hopkins, D. Brett; Park, Tristan (2020). "Vaping among youth and young adults: a "red alert" state". Journal of Public Health Policy. 41 (1): 63–69. doi:10.1057/s41271-019-00193-2. ISSN 0197-5897. PMID 31664162. S2CID 204966830.
26. "What's in an E-Cigarette?". American Lung Association. 2023.
27. ^ Farsalinos KE; Spyrou A; Tsimopoulou K; Stefopoulos C; Romagna G; Voudris V (2014). "Nicotine absorption from electronic cigarette use: Comparison between first and new-generation devices". Scientific Reports. 4: 4133. Bibcode:2014NatSR...4E4133F. doi:10.1038/srep04133. PMC 3935206. PMID 24569565.
28. ^ Bhatnagar, Aruni; Whitsel, Laurie P.; Ribisl, Kurt M.; Bullen, Chris; Chaloupka, Frank; Piano, Mariann R.; Robertson, Rose Marie; McAuley, Timothy; Goff, David; Benowitz, Neal (14 October 2014) . "Electronic Cigarettes: A Policy Statement From the American Heart Association". Circulation. 130 (16): 1418–1436. doi:10.1161/CIR.0000000000000107. PMC 7643636. PMID 25156991.
29. Hayden McRobbie (2014). "Electronic cigarettes" (PDF). National Centre for Smoking Cessation and Training. pp. 1–16. Archived from the original (PDF) on 23 April 2022. Retrieved 4 June 2014.
30. Konstantinos Farsalinos (2015). "Electronic cigarette evolution from the first to fourth generation and beyond" (PDF). Global Forum on Nicotine. p. 23. Archived from the original (PDF) on 8 July 2015.
31. ^ Jenssen, Brian P.; Boykan, Rachel (2019). "Electronic Cigarettes and Youth in the United States: A Call to Action (at the Local, National and Global Levels)". Children. 6 (2): 30. doi:10.3390/children6020030. ISSN 2227-9067. PMC 6406299. PMID 30791645. This article incorporates text by Brian P. Jenssen and Rachel Boykan available under the CC BY 4.0 license.
32. Weedston, Lindsey (8 April 2019). "FDA To Investigate Whether Vaping Causes Seizures". The Fix.
33. Barrington-Trimis, Jessica L.; Leventhal, Adam M. (2018). "Adolescents' Use of "Pod Mod" E-Cigarettes — Urgent Concerns". New England Journal of Medicine. 379 (12): 1099–1102. doi:10.1056/NEJMp1805758. ISSN 0028-4793. PMC 7489756. PMID 30134127.
34. Jankowski, Mateusz; Brożek, Grzegorz; Lawson, Joshua; Skoczyński, Szymon; Zejda, Jan (2017). "E-smoking: Emerging public health problem?". International Journal of Occupational Medicine and Environmental Health. 30 (3): 329–344. doi:10.13075/ijomeh.1896.01046. ISSN 1232-1087. PMID 28481369.
35. ^ Bertholon, J.F.; Becquemin, M.H.; Annesi-Maesano, I.; Dautzenberg, B. (2013). "Electronic Cigarettes: A Short Review". Respiration. 86 (5): 433–8. doi:10.1159/000353253. ISSN 1423-0356. PMID 24080743.
36. ^ England, Lucinda J.; Bunnell, Rebecca E.; Pechacek, Terry F.; Tong, Van T.; McAfee, Tim A. (2015). "Nicotine and the Developing Human". American Journal of Preventive Medicine. 49 (2): 286–93. doi:10.1016/j.amepre.2015.01.015. ISSN 0749-3797. PMC 4594223. PMID 25794473.
37. Jimenez Ruiz, CA; Solano Reina, S; de Granda Orive, JI; Signes-Costa Minaya, J; de Higes Martinez, E; Riesco Miranda, JA; Altet Gómez, N; Lorza Blasco, JJ; Barrueco Ferrero, M; de Lucas Ramos, P (August 2014). "The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes". Archivos de Bronconeumologia. 50 (8): 362–7. doi:10.1016/j.arbres.2014.02.006. PMID 24684764.
38. Dan Nosowitz (5 June 2015). "America's First Certified Organic E-Cigarette Vaping Liquid Is Here". Modern Farmer.
39. Thirión-Romero, Ireri; Pérez-Padilla, Rogelio; Zabert, Gustavo; Barrientos-Gutiérrez, Inti (2019). "Respiratory Impact of Electronic Cigarettes and Low-Risk Tobacco". Revista de investigación Clínica. 71 (1): 17–27. doi:10.24875/RIC.18002616. ISSN 0034-8376. PMID 30810544. S2CID 73511138.
40. John Reid Blackwell (7 June 2015). "Avail Vapor offers glimpse into the 'art and science' of e-liquids". Richmond Times-Dispatch.
41. Henry, Travis S.; Kligerman, Seth J.; Raptis, Constantine A.; Mann, Howard; Sechrist, Jacob W.; Kanne, Jeffrey P. (2020). "Imaging Findings of Vaping-Associated Lung Injury". American Journal of Roentgenology. 214 (3): 498–505. doi:10.2214/AJR.19.22251. ISSN 0361-803X. PMID 31593518. S2CID 203985885.
42. "Manufacturing". United States Food and Drug Administration. 12 August 2016.
43. E-Liquid Manufacturing Standards (PDF). US: American E-Liquid Manufacturing Standards Association (AEMSA). 4 September 2015. pp. 1–13.
44. Famele, M.; Ferranti, C.; Abenavoli, C.; Palleschi, L.; Mancinelli, R.; Draisci, R. (2014). "The Chemical Components of Electronic Cigarette Cartridges and Refill Fluids: Review of Analytical Methods". Nicotine & Tobacco Research. 17 (3): 271–279. doi:10.1093/ntr/ntu197. ISSN 1462-2203. PMC 5479507. PMID 25257980.
45. "Toxic metal, leached from e-cigarette coil, permanently scars woman's lung". NBC News.
46. ^ Rom, Oren; Pecorelli, Alessandra; Valacchi, Giuseppe; Reznick, Abraham Z. (2014). "Are E-cigarettes a safe and good alternative to cigarette smoking?". Annals of the New York Academy of Sciences. 1340 (1): 65–74. Bibcode:2015NYASA1340...65R. doi:10.1111/nyas.12609. ISSN 0077-8923. PMID 25557889. S2CID 26187171.
47. Bourke, Liam; Bauld, Linda; Bullen, Christopher; Cumberbatch, Marcus; Giovannucci, Edward; Islami, Farhad; McRobbie, Hayden; Silverman, Debra T.; Catto, James W.F. (2017). "E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks" (PDF). European Urology. 71 (6): 915–923. doi:10.1016/j.eururo.2016.12.022. hdl:1893/24937. ISSN 0302-2838. PMID 28073600.
48. ^ Schraufnagel, Dean E.; Blasi, Francesco; Drummond, M. Bradley; Lam, David C. L.; Latif, Ehsan; Rosen, Mark J.; Sansores, Raul; Van Zyl-Smit, Richard (2014). "Electronic Cigarettes. A Position Statement of the Forum of International Respiratory Societies". American Journal of Respiratory and Critical Care Medicine. 190 (6): 611–618. doi:10.1164/rccm.201407-1198PP. ISSN 1073-449X. PMID 25006874. S2CID 43763340.
49. Shapiro, Harry (2020). "Burning Issues: The Global State of Tobacco Harm Reduction".
50. "82 million vapers worldwide in 2021: the GSTHR estimate". Global State of Tobacco Harm Reduction. Retrieved 13 November 2022.
51. Camenga, Deepa R.; Klein, Jonathan D. (2016). "Tobacco Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 25 (3): 445–460. doi:10.1016/j.chc.2016.02.003. ISSN 1056-4993. PMC 4920978. PMID 27338966.
52. ^ Cai, Hua; Wang, Chen (2017). "Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns". Redox Biology. 13: 402–406. doi:10.1016/j.redox.2017.05.013. ISSN 2213-2317. PMC 5493817. PMID 28667909.
53. Aguilar, Carmen (11 June 2018). "Lung cancer deaths on the rise in two thirds of European countries". VoxEurop/The European Data Journalism Network (EDJNet).
54. ^ Siu, AL (22 September 2015). "Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 163 (8): 622–634. doi:10.7326/M15-2023. PMID 26389730.
55. ^ Glantz, Stanton A.; Bareham, David W. (January 2018). "E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications". Annual Review of Public Health. 39 (1): 215–235. doi:10.1146/annurev-publhealth-040617-013757. ISSN 0163-7525. PMC 6251310. PMID 29323609. This article incorporates text by Stanton A. Glantz and David W. Bareham available under the CC BY 4.0 license.
56. Tomashefski, A (21 March 2016). "The perceived effects of electronic cigarettes on health by adult users: A state of the science systematic literature review". Journal of the American Association of Nurse Practitioners. 28 (9): 510–515. doi:10.1002/2327-6924.12358. PMID 26997487. S2CID 42900184.
57. Wang, Meng; Wang, Jian-Wei; Cao, Shuang-Shuang; Wang, Hui-Qin; Hu, Ru-Ying (2016). "Cigarette Smoking and Electronic Cigarettes Use: A Meta-Analysis". International Journal of Environmental Research and Public Health. 13 (1): 120. doi:10.3390/ijerph13010120. ISSN 1660-4601. PMC 4730511. PMID 26771624.
58. McNeill 2018, p. 178.
59. ^ Hefner, Kathryn; Valentine, Gerald; Sofuoglu, Mehmet (2017). "Electronic cigarettes and mental illness: Reviewing the evidence for help and harm among those with psychiatric and substance use disorders". The American Journal on Addictions. 26 (4): 306–315. doi:10.1111/ajad.12504. ISSN 1055-0496. PMID 28152247. S2CID 24298173. This article incorporates text from this source, which is in the public domain.
60. ^ Gibson, Laura A.; Creamer, MeLisa R.; Breland, Alison B.; Giachello, Aida Luz; Kaufman, Annette; Kong, Grace; Pechacek, Terry F.; Pepper, Jessica K.; Soule, Eric K.; Halpern-Felsher, Bonnie (2018). "Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity". Addictive Behaviors. 79: 219–225. doi:10.1016/j.addbeh.2017.11.017. ISSN 0306-4603. PMC 5807230. PMID 29175027.
61. Lee, Peter N (2015). "Appropriate and inappropriate methods for investigating the "gateway" hypothesis, with a review of the evidence linking prior snus use to later cigarette smoking". Harm Reduction Journal. 12 (1): 8. doi:10.1186/s12954-015-0040-7. ISSN 1477-7517. PMC 4369866. PMID 25889396. This article incorporates text by Peter N Lee available under the CC BY 4.0 license.
62. Baenziger, Olivia; Ford, Laura; Yazidjoglou, Amelia; Joshy, Grace; Banks, Emily (2021). "E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis". BMJ Open. 11 (3): e045603. doi:10.1136/bmjopen-2020-045603. ISSN 2044-6055. PMC 8011717. PMID 33785493.
63. ^ WHO 2014, p. 6.
64. Franck, C.; Budlovsky, T.; Windle, S. B.; Filion, K. B.; Eisenberg, M. J. (2014). "Electronic Cigarettes in North America: History, Use, and Implications for Smoking Cessation". Circulation. 129 (19): 1945–1952. doi:10.1161/CIRCULATIONAHA.113.006416. ISSN 0009-7322. PMID 24821825.
65. Yoong, Sze Lin; Hall, Alix; Turon, Heidi; Stockings, Emily; Leonard, Alecia; Grady, Alice; Tzelepis, Flora; Wiggers, John; Gouda, Hebe; Fayokun, Ranti; Commar, Alison; Prasad, Vinayak M; Wolfenden, Luke (2021). "Association between electronic nicotine delivery systems and electronic non-nicotine delivery systems with initiation of tobacco use in individuals aged < 20 years. A systematic review and meta-analysis". PLOS ONE. 16 (9). e0256044. Bibcode:2021PLoSO..1656044Y. doi:10.1371/journal.pone.0256044. eISSN 1932-6203. PMC 8425526. PMID 34495974.
66. Dautzenberg, B.; Adler, M.; Garelik, D.; Loubrieu, J.F.; Mathern, G.; Peiffer, G.; Perriot, J.; Rouquet, R.M.; Schmitt, A.; Underner, M.; Urban, T. (2017). "Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement". Revue des Maladies Respiratoires. 34 (2): 155–164. doi:10.1016/j.rmr.2017.01.001. ISSN 0761-8425. PMID 28189437.
67. Nansseu, Jobert Richie N.; Bigna, Jean Joel R. (2016). "Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa". Pulmonary Medicine. 2016: 1–9. doi:10.1155/2016/4894352. ISSN 2090-1836. PMC 5220510. PMID 28116156. This article incorporates text by Jobert Richie N. Nansseu and Jean Joel R. Bigna available under the CC BY 4.0 license.
68. Etter, Jean-François (19 June 2017). "Gateway effects and electronic cigarettes: Gateway effects and e-cigarettes". Addiction. 113 (10): 1776–1783. doi:10.1111/add.13924. PMID 28786147.
69. ^ Hall, Wayne; Chan, Gary (18 March 2021). "The "gateway" effect of e-cigarettes may be explained by a genetic liability to risk-taking". PLOS Medicine. 18 (3): e1003554. doi:10.1371/journal.pmed.1003554. ISSN 1549-1676. PMC 7971461. PMID 33735167.
70. ^ Kozlowski, Lynn T.; Warner, Kenneth E. (1 May 2017). "Adolescents and e-cigarettes: Objects of concern may appear larger than they are". Drug and Alcohol Dependence. 174: 209–214. doi:10.1016/j.drugalcdep.2017.01.001. ISSN 0376-8716. PMID 29350617.
71. Khouja, Jasmine N.; Wootton, Robyn E.; Taylor, Amy E.; Smith, George Davey; Munafò, Marcus R. (18 March 2021). "Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study". PLOS Medicine. 18 (3): e1003555. doi:10.1371/journal.pmed.1003555. ISSN 1549-1676. PMC 7971530. PMID 33735204.
72. Pentz, Mary Ann; Shin, HeeSung; Riggs, Nathaniel; Unger, Jennifer B.; Collison, Katherine L.; Chou, Chih-Ping (1 March 2015). "Parent, peer, and executive function relationships to early adolescent e-cigarette use: A substance use pathway?". Addictive Behaviors. 42: 73–78. doi:10.1016/j.addbeh.2014.10.040. ISSN 0306-4603. PMC 4292878. PMID 25462657.
73. Bentivegna, Kathryn; Atuegwu, Nkiruka C.; Oncken, Cheryl; DiFranza, Joseph R.; Mortensen, Eric M. (1 January 2021). "Electronic Cigarettes Associated With Incident and Polysubstance Use Among Youth". Journal of Adolescent Health. 68 (1): 123–129. doi:10.1016/j.jadohealth.2020.05.026. ISSN 1054-139X. PMID 32641242. S2CID 220435106.
74. Chan, Gary C. K.; Stjepanović, Daniel; Lim, Carmen; Sun, Tianze; Shanmuga Anandan, Aathavan; Connor, Jason P.; Gartner, Coral; Hall, Wayne D.; Leung, Janni (4 September 2020). "Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation". Addiction. 116 (4): 743–756. doi:10.1111/add.15246. ISSN 0965-2140. PMID 32888234. S2CID 221503932. Only two studies comprehensively adjusted for confounding. The median E‐value was 2.90, indicating that the estimates were not robust against unmeasured confounding.
75. Phillips, Carl V. (21 May 2015). "Gateway Effects: Why the Cited Evidence Does Not Support Their Existence for Low-Risk Tobacco Products (and What Evidence Would)". International Journal of Environmental Research and Public Health. 12 (5): 5439–5464. doi:10.3390/ijerph120505439. ISSN 1660-4601. PMC 4454978. PMID 26006122.
76. Khouja, Jasmine N.; Suddell, Steph F.; Peters, Sarah E.; Taylor, Amy E.; Munafò, Marcus R. (1 January 2021). "Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis". Tobacco Control. 30 (1): 8–15. doi:10.1136/tobaccocontrol-2019-055433. ISSN 0964-4563. PMC 7803902. PMID 32156694. None of the studies included negative controls which would provide stronger evidence for whether the association may be causal.
77. Chapman, Simon; Bareham, David; Maziak, Wasim (17 April 2019). "The Gateway Effect of E-cigarettes: Reflections on Main Criticisms". Nicotine & Tobacco Research. 21 (5): 695–698. doi:10.1093/ntr/nty067. ISSN 1469-994X. PMC 6468127. PMID 29660054.
78. Jones, Kristen; Salzman, Gary A. (2020). "The Vaping Epidemic in Adolescents". Missouri Medicine. 117 (1): 56–58. PMC 7023954. PMID 32158051.
79. Schneider, Sven; Diehl, Katharina (2016). "Vaping as a Catalyst for Smoking? An Initial Model on the Initiation of Electronic Cigarette Use and the Transition to Tobacco Smoking Among Adolescents". Nicotine & Tobacco Research. 18 (5): 647–653. doi:10.1093/ntr/ntv193. ISSN 1462-2203. PMID 26386472.
80. Yoong, Sze Lin; Stockings, Emily; Chai, Li Kheng; Tzelepis, Flora; Wiggers, John; Oldmeadow, Christopher; Paul, Christine; Peruga, Armando; Kingsland, Melanie; Attia, John; Wolfenden, Luke (2018). "Prevalence of electronic nicotine delivery systems (ENDS) use among youth globally: a systematic review and meta-analysis of country level data". Australian and New Zealand Journal of Public Health. 42 (3): 303–308. doi:10.1111/1753-6405.12777. ISSN 1326-0200. PMID 29528527.
81. Levy, David T.; Warner, Kenneth E.; Cummings, K. Michael; Hammond, David; Kuo, Charlene; Fong, Geoffrey T.; Thrasher, James F.; Goniewicz, Maciej Lukasz; Borland, Ron (1 November 2019). "Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check". Tobacco Control. 28 (6): 629–635. doi:10.1136/tobaccocontrol-2018-054446. ISSN 0964-4563. PMC 6860409. PMID 30459182.
82. West, Robert; Brown, Jamie; Jarvis, Martin (7 October 2019). "Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey reveal about high school e-cigarette use in the USA? (Preprint)". Qeios. doi:10.32388/745076.3. ISSN 2632-3834. Retrieved 24 February 2020.
83. Hallingberg, Britt; Maynard, Olivia M.; Bauld, Linda; Brown, Rachel; Gray, Linsay; Lowthian, Emily; MacKintosh, Anne-Marie; Moore, Laurence; Munafo, Marcus R.; Moore, Graham (1 March 2020). "Have e-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales". Tobacco Control. 29 (2): 207–216. doi:10.1136/tobaccocontrol-2018-054584. ISSN 0964-4563. PMC 7036293. PMID 30936390.
84. "Historical NYTS Data and Documentation". www.cdc.gov. Centers for Disease Control and Prevention. 17 December 2019. Retrieved 24 February 2020.
85. Zhong, Jieming; Cao, Shuangshuang; Gong, Weiwei; Fei, Fangrong; Wang, Meng (2016). "Electronic Cigarettes Use and Intention to Cigarette Smoking among Never-Smoking Adolescents and Young Adults: A Meta-Analysis". International Journal of Environmental Research and Public Health. 13 (5): 465. doi:10.3390/ijerph13050465. ISSN 1660-4601. PMC 4881090. PMID 27153077.
86. ^ Grana, R; Benowitz, N; Glantz, SA (13 May 2014). "E-cigarettes: a scientific review". Circulation. 129 (19): 1972–86. doi:10.1161/circulationaha.114.007667. PMC 4018182. PMID 24821826.
87. Modesto-Lowe, Vania; Alvarado, Camille (2017). "E-cigs ... Are They Cool? Talking to Teens About E-Cigarettes". Clinical Pediatrics. 56 (10): 947–952. doi:10.1177/0009922817705188. ISSN 0009-9228. PMID 28443340. S2CID 44423931.
88. ^ U.S. Department of Health and Human Services (2016). E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General (PDF) (Report). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. pp. 1–298. This article incorporates text from this source, which is in the public domain.
89. Chadi, Nicholas; Schroeder, Rachel; Jensen, Jens Winther; Levy, Sharon (2019). "Association Between Electronic Cigarette Use and Marijuana Use Among Adolescents and Young Adults". JAMA Pediatrics. 173 (10): e192574. doi:10.1001/jamapediatrics.2019.2574. ISSN 2168-6203. PMC 6692686. PMID 31403684.
90. ^ Cormet-Boyaka, Estelle; Zare, Samane; Nemati, Mehdi; Zheng, Yuqing (2018). "A systematic review of consumer preference for e-cigarette attributes: Flavor, nicotine strength, and type". PLOS ONE. 13 (3). e0194145. Bibcode:2018PLoSO..1394145Z. doi:10.1371/journal.pone.0194145. ISSN 1932-6203. PMC 5854347. PMID 29543907. This article incorporates text by Samane Zare, Mehdi Nemati, and Yuqing Zheng available under the CC BY 4.0 license.
91. ^ Chatterjee, Kshitij; Alzghoul, Bashar; Innabi, Ayoub; Meena, Nikhil (2018). "Is vaping a gateway to smoking: a review of the longitudinal studies". International Journal of Adolescent Medicine and Health. 30 (3). doi:10.1515/ijamh-2016-0033. ISSN 2191-0278. PMID 27505084. S2CID 23977146.
92. ^ Knorst, Marli Maria; Benedetto, Igor Gorski; Hoffmeister, Mariana Costa; Gazzana, Marcelo Basso (2014). "The electronic cigarette: the new cigarette of the 21st century?". Jornal Brasileiro de Pneumologia. 40 (5): 564–572. doi:10.1590/S1806-37132014000500013. ISSN 1806-3713. PMC 4263338. PMID 25410845.
93. ^ Hildick-Smith, Gordon J.; Pesko, Michael F.; Shearer, Lee; Hughes, Jenna M.; Chang, Jane; Loughlin, Gerald M.; Ipp, Lisa S. (2015). "A Practitioner's Guide to Electronic Cigarettes in the Adolescent Population". Journal of Adolescent Health. 57 (6): 574–579. doi:10.1016/j.jadohealth.2015.07.020. ISSN 1054-139X. PMID 26422289.
94. ^ Schraufnagel, Dean E. (2015). "Electronic Cigarettes: Vulnerability of Youth". Pediatric Allergy, Immunology, and Pulmonology. 28 (1): 2–6. doi:10.1089/ped.2015.0490. ISSN 2151-321X. PMC 4359356. PMID 25830075.
95. ^ Virgili, Fabrizio; Nenna, Raffaella; Ben David, Shira; Mancino, Enrica; Di Mattia, Greta; Matera, Luigi; Petrarca, Laura; Midulla, Fabio (December 2022). "E-cigarettes and youth: an unresolved Public Health concern". Italian Journal of Pediatrics. 48 (1): 97. doi:10.1186/s13052-022-01286-7. ISSN 1824-7288. PMC 9194784. PMID 35701844.
96. Sun, Jiahong; Xi, Bo; Ma, Chuanwei; Zhao, Min; Bovet, Pascal (April 2022). "Prevalence of E-Cigarette Use and Its Associated Factors Among Youths Aged 12 to 16 Years in 68 Countries and Territories: Global Youth Tobacco Survey, 2012‒2019". American Journal of Public Health. 112 (4): 650–661. doi:10.2105/AJPH.2021.306686. ISSN 0090-0036. PMC 8961851. PMID 35319939.
97. Paley, Grace L.; Echalier, Elizabeth; Eck, Thomas W.; Hong, Augustine R.; Farooq, Asim V.; Gregory, Darren G.; Lubniewski, Anthony J. (2016). "Corneoscleral Laceration and Ocular Burns Caused by Electronic Cigarette Explosions". Cornea. 35 (7): 1015–1018. doi:10.1097/ICO.0000000000000881. ISSN 0277-3740. PMC 4900417. PMID 27191672.
98. Gotts, Jeffrey E; Jordt, Sven-Eric; McConnell, Rob; Tarran, Robert (2019). "What are the respiratory effects of e-cigarettes?". BMJ. 366: l5275. doi:10.1136/bmj.l5275. ISSN 0959-8138. PMC 7850161. PMID 31570493.
99. ^ Burstyn, Igor (9 January 2014). "Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks". BMC Public Health. 14 (1): 18. doi:10.1186/1471-2458-14-18. ISSN 1471-2458. PMC 3937158. PMID 24406205.
100. ^ Wills, Thomas A.; Soneji, Samir S.; Choi, Kelvin; Jaspers, Ilona; Tam, Elizabeth K. (10 October 2020). "E-cigarette Use and Respiratory Disorder: An Integrative Review of Converging Evidence from Epidemiological and Laboratory Studies". European Respiratory Journal. 56 (5): 363–380. doi:10.1183/13993003.01815-2019. ISSN 1399-3003. PMC 7817920. PMID 33154031.
101. Albert D. Osei; Mohammadhassan Mirbolouk; Olusola A. Orimoloye; Omar Dzaye; S.M. Iftekhar Uddin; Emelia J. Benjamin; Michael E. Hall; Andrew P. DeFilippis; Aruni Bhatnagar; Shyam S. Biswal; Michael J. Blaha (1 January 2020). "Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017". American Journal of Preventive Medicine. 58 (3): 336–332. doi:10.1016/j.amepre.2019.10.014. PMC 9843649. PMID 31902685.
102. ^ Breland, Alison B.; Spindle, Tory; Weaver, Michael; Eissenberg, Thomas (2014). "Science and Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 223–233. doi:10.1097/ADM.0000000000000049. ISSN 1932-0620. PMC 4122311. PMID 25089952.
103. Edgar, Julie (12 November 2013). "E-Cigarettes: Expert Q&A With the CDC". WebMD.
104. Boudi, F Brian; Patel, Sonia; Boudi, Ava; Chan, Connie (2019). "Vitamin E Acetate as a Plausible Cause of Acute Vaping-related Illness". Cureus. 11 (12): e6350. doi:10.7759/cureus.6350. ISSN 2168-8184. PMC 6952050. PMID 31938636. This article incorporates text by F Brian Boudi, Sonia Patel, Ava Boudi, Connie Chan available under the CC BY 3.0 license.
105. King, Brian A.; Jones, Christopher M.; Baldwin, Grant T.; Briss, Peter A. (2020). "The EVALI and Youth Vaping Epidemics — Implications for Public Health". New England Journal of Medicine. 382 (8): 689–691. doi:10.1056/NEJMp1916171. ISSN 0028-4793. PMC 7122126. PMID 31951683.
106. "Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products". Centers for Disease Control and Prevention. 17 January 2020.
107. ^ Li, Liqiao; Lin, Yan; Xia, Tian; Zhu, Yifang (7 January 2020). "Effects of Electronic Cigarettes on Indoor Air Quality and Health". Annual Review of Public Health. 41: 363–380. doi:10.1146/annurev-publhealth-040119-094043. ISSN 0163-7525. PMC 7346849. PMID 31910714.
108. Qasim, Hanan; Karim, Zubair A.; Rivera, Jose O.; Khasawneh, Fadi T.; Alshbool, Fatima Z. (2017). "Impact of Electronic Cigarettes on the Cardiovascular System". Journal of the American Heart Association. 6 (9): e006353. doi:10.1161/JAHA.117.006353. ISSN 2047-9980. PMC 5634286. PMID 28855171.
109. Kapaya, Martha (2019). "Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth — Oklahoma and Texas, 2015". MMWR. Morbidity and Mortality Weekly Report. 68 (8): 189–194. doi:10.15585/mmwr.mm6808a1. PMC 6394383. PMID 30817748.
110. Liu, Buyun; Xu, Guifeng; Rong, Shuang; Santillan, Donna A.; Santillan, Mark K.; Snetselaar, Linda G.; Bao, Wei (2019). "National Estimates of e-Cigarette Use Among Pregnant and Nonpregnant Women of Reproductive Age in the United States, 2014-2017". JAMA Pediatrics. 173 (6): 600–602. doi:10.1001/jamapediatrics.2019.0658. ISSN 2168-6211. PMC 6547070. PMID 31034001.
111. Pesko, Michael F.; Currie, Janet M. (1 July 2019). "E-cigarette minimum legal sale age laws and traditional cigarette use among rural pregnant teenagers". Journal of Health Economics. 66: 71–90. doi:10.1016/j.jhealeco.2019.05.003. ISSN 0167-6296. PMC 7051858. PMID 31121389.
112. National Academies of Sciences, Engineering, and Medicine 2018, 13 Developmental and Reproductive Effects
113. "E-Cigarettes and Pregnancy". Centers for Disease Control. March 2019.
114. Sampath, Uday; Tanna, Shivani; Sharma, Akriti (6 July 2022). "Juul ban put on hold as FDA starts additional review". Reuters. Retrieved 15 January 2023.
115. Laura Kelly and Tom Howell Jr. (25 April 2018). "JUUL, maker of popular e-cigarettes, invests $30M in youth awareness". The Washington Times.
116. Willett, Jeffrey G; Bennett, Morgane; Hair, Elizabeth C; Xiao, Haijuan; Greenberg, Marisa S; Harvey, Emily; Cantrell, Jennifer; Vallone, Donna (18 April 2018). "Recognition, use and perceptions of JUUL among youth and young adults" (PDF). Tobacco Control. 28 (1): tobaccocontrol–2018–054273. doi:10.1136/tobaccocontrol-2018-054273. PMID 29669749. S2CID 4953543. Archived from the original (PDF) on 7 December 2018.
117. ^ Kimberly Suiters (31 January 2018). "Are your kids juuling at school? 7 On Your Side investigates". WJLA-TV. Archived from the original on 22 June 2018. Retrieved 29 September 2018.
118. Barshad, Amos (7 April 2018). "The Juul Is Too Cool". The New York Times.
119. Detailed reference list is located at a separate image page.
120. ^ Abrams, David B.; Glasser, Allison M.; Pearson, Jennifer L.; Villanti, Andrea C.; Collins, Lauren K.; Niaura, Raymond S. (2018). "Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives". Annual Review of Public Health. 39 (1): 193–213. doi:10.1146/annurev-publhealth-040617-013849. ISSN 0163-7525. PMC 6942997. PMID 29323611. This article incorporates text by David B. Abrams, Allison M. Glasser, Jennifer L. Pearson, Andrea C. Villanti, Lauren K. Collins, and Raymond S. Niaura available under the CC BY 4.0 license.
121. ^ Cahn, Z.; Siegel, M. (February 2011). "Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?". Journal of Public Health Policy. 32 (1): 16–31. doi:10.1057/jphp.2010.41. PMID 21150942.
122. ^ Britton, John; Bogdanovica, Ilze (15 May 2014). "Electronic cigarettes – A report commissioned by Public Health England" (PDF). Public Health England.
123. Ferkol, Thomas W.; Farber, Harold J.; La Grutta, Stefania; Leone, Frank T.; Marshall, Henry M.; Neptune, Enid; Pisinger, Charlotta; Vanker, Aneesa; Wisotzky, Myra; Zabert, Gustavo E.; Schraufnagel, Dean E. (2018). "Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies". European Respiratory Journal. 51 (5): 1800278. doi:10.1183/13993003.00278-2018. ISSN 0903-1936. PMID 29848575.
124. Scherer, Gerhard (2018). "Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review". Regulatory Toxicology and Pharmacology. 94: 203–233. doi:10.1016/j.yrtph.2018.02.002. ISSN 0273-2300. PMID 29428304.
125. Oh, Anne Y.; Kacker, Ashutosh (December 2014). "Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes?: Review on e-cigarette vapor versus tobacco smoke". The Laryngoscope. 124 (12): 2702–2706. doi:10.1002/lary.24750. PMID 25302452. S2CID 10560264.
126. ^ Wilder 2016, p. 82.
127. ^ Franck, Caroline; Filion, Kristian B.; Kimmelman, Jonathan; Grad, Roland; Eisenberg, Mark J. (2016). "Ethical considerations of e-cigarette use for tobacco harm reduction". Respiratory Research. 17 (1): 53. doi:10.1186/s12931-016-0370-3. ISSN 1465-993X. PMC 4869264. PMID 27184265. This article incorporates text by Caroline Franck, Kristian B. Filion, Jonathan Kimmelman, Roland Grad and Mark J. Eisenberg available under the CC BY 4.0 license.
128. Warner, Kenneth E.; Kiessling, Karalyn A.; Douglas, Clifford E.; Liber, Alex C. (1 September 2022). "A Proposed Policy Agenda For Electronic Cigarettes In The US: Product, Price, Place, And Promotion: Policy Insight offers a proposed agenda for electronic cigarettes in the United States: product, price, place, and promotion". Health Affairs. 41 (9): 1299–1306. doi:10.1377/hlthaff.2022.00187. ISSN 0278-2715. PMID 36067433. S2CID 252110211.
129. ^ Drummond, MB; Upson, D (February 2014). "Electronic cigarettes. Potential harms and benefits". Annals of the American Thoracic Society. 11 (2): 236–242. doi:10.1513/annalsats.201311-391fr. PMC 5469426. PMID 24575993.
130. ^ Franks, Andrea S; Sando, Karen; McBane, Sarah (2018). "Do Electronic Cigarettes Have a Role in Tobacco Cessation?". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 38 (5): 555–568. doi:10.1002/phar.2103. ISSN 0277-0008. PMID 29573440. S2CID 4365503.
131. V.Courtney Broaddus; Robert C Mason; Joel D Ernst; Talmadge E King Jr.; Stephen C Lazarus; John F. Murray; Jay A. Nadel; Arthur Slutsky; Michael Gotway (17 March 2015). Murray & Nadel's Textbook of Respiratory Medicine. Elsevier Health Sciences. p. 820. ISBN 978-0-323-26193-7.
132. ^ Hajek, P; Etter, JF; Benowitz, N; Eissenberg, T; McRobbie, H (31 July 2014). "Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit". Addiction. 109 (11): 1801–1810. doi:10.1111/add.12659. PMC 4487785. PMID 25078252.
133. ^ Saitta, D; Ferro, GA; Polosa, R (March 2014). "Achieving appropriate regulations for electronic cigarettes". Therapeutic Advances in Chronic Disease. 5 (2): 50–61. doi:10.1177/2040622314521271. PMC 3926346. PMID 24587890.
134. Caponnetto, Pasquale; Campagna, Davide; Papale, Gabriella; Russo, Cristina; Polosa, Riccardo (2012). "The emerging phenomenon of electronic cigarettes". Expert Review of Respiratory Medicine. 6 (1): 63–74. doi:10.1586/ers.11.92. ISSN 1747-6348. PMID 22283580. S2CID 207223131.
135. ^ Nowak D; Jörres RA; Rüther T (2014). "E-cigarettes—prevention, pulmonary health, and addiction". Dtsch Ärztebl Int. 111 (20): 349–55. doi:10.3238/arztebl.2014.0349. PMC 4047602. PMID 24882626.
136. "BMA calls for stronger regulation of e-cigarettes" (PDF). British Medical Association. January 2013. Archived from the original (PDF) on 7 November 2013. Retrieved 11 August 2013.
137. "Principles to Guide AAPHP Tobacco Policy". American Association of Public Health Physicians. June 2013.
138. Orellana-Barrios MA; Payne D; Medrano-Juarez RM; Yang S; Nugent K (2016). "Electronic Cigarettes for Smoking Cessation". The American Journal of the Medical Sciences. 52 (4): 420–426. doi:10.1016/j.amjms.2016.07.013. PMID 27776725. S2CID 23548705.
139. Hartmann-Boyce, Jamie; McRobbie, Hayden; Butler, Ailsa R.; Lindson, Nicola; Bullen, Chris; Begh, Rachna; Theodoulou, Annika; Notley, Caitlin; Rigotti, Nancy A.; Turner, Tari; Fanshawe, Thomas R. (14 September 2021). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 9 (11): CD010216. doi:10.1002/14651858.CD010216.pub6. ISSN 1469-493X. PMC 8438601. PMID 34519354.
140. Traboulsi, Hussein; Cherian, Mathew; Abou Rjeili, Mira; Preteroti, Matthew; Bourbeau, Jean; Smith, Benjamin M.; Eidelman, David H.; Baglole, Carolyn J. (15 May 2020). "Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health". International Journal of Molecular Sciences. 21 (10): 3495. doi:10.3390/ijms21103495. PMC 7278963. PMID 32429092.
141. Patil, Shankargouda; Arakeri, Gururaj; Patil, Shekar; Ali Baeshen, Hosam; Raj, Thirumal; Sarode, Sachin C.; Sarode, Gargi S.; Awan, Kamran H.; Gomez, Ricardo; Brennan, Peter A (2019). "Are electronic nicotine delivery systems (ENDs) helping cigarette smokers quit? – A current evidence". Journal of Oral Pathology & Medicine. 49 (3): 181–189. doi:10.1111/jop.12966. ISSN 0904-2512. PMID 31642553. S2CID 204850725.
142. ^ El Dib, Regina; Suzumura, Erica A; Akl, Elie A; Gomaa, Huda; Agarwal, Arnav; Chang, Yaping; Prasad, Manya; Ashoorion, Vahid; Heels-Ansdell, Diane; Maziak, Wasim; Guyatt, Gordon (2017). "Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis". BMJ Open. 7 (2): e012680. doi:10.1136/bmjopen-2016-012680. ISSN 2044-6055. PMC 5337697. PMID 28235965.
143. Orr, KK; Asal, NJ (November 2014). "Efficacy of electronic cigarettes for smoking cessation". The Annals of Pharmacotherapy. 48 (11): 1502–1506. doi:10.1177/1060028014547076. PMID 25136064. S2CID 29307238.
144. ^ Bullen, Christopher (2014). "Electronic Cigarettes for Smoking Cessation". Current Cardiology Reports. 16 (11): 538. doi:10.1007/s11886-014-0538-8. ISSN 1523-3782. PMID 25303892. S2CID 2550483.
145. Malas, Muhannad; van der Tempel, Jan; Schwartz, Robert; Minichiello, Alexa; Lightfoot, Clayton; Noormohamed, Aliya; Andrews, Jaklyn; Zawertailo, Laurie; Ferrence, Roberta (25 April 2016). "Electronic Cigarettes for Smoking Cessation: A Systematic Review". Nicotine & Tobacco Research. 18 (10): 1926–1936. doi:10.1093/ntr/ntw119. ISSN 1462-2203. PMID 27113014.
146. Vanderkam, Paul; Boussageon, Rémy; Underner, Michel; Langbourg, Nicolas; Brabant, Yann; Binder, Philippe; Freche, Bernard; Jaafari, Nematollah (2016). "Efficacité et sécurité de la cigarette électronique pour la réduction du tabagisme : revue systématique et méta-analyse". La Presse Médicale. 45 (11): 971–985. doi:10.1016/j.lpm.2016.05.026. ISSN 0755-4982. PMID 27597300.
147. ^ McRobbie, Hayden; Bullen, Chris; Hartmann-Boyce, Jamie; Hajek, Peter; McRobbie, Hayden (2014). "Electronic cigarettes for smoking cessation and reduction". The Cochrane Database of Systematic Reviews. 12 (12): CD010216. doi:10.1002/14651858.CD010216.pub2. hdl:2292/27824. PMID 25515689.
148. ^ Jerry JM; Collins GB; Streem D (2015). "E-cigarettes: Safe to recommend to patients?". Cleve Clin J Med. 82 (8): 521–526. doi:10.3949/ccjm.82a.14054. PMID 26270431.
149. ^ Hartmann-Boyce, Jamie; McRobbie, Hayden; Bullen, Chris; Begh, Rachna; Stead, Lindsay F; Hajek, Peter; Hartmann-Boyce, Jamie (2016). "Electronic cigarettes for smoking cessation". Cochrane Database Syst Rev. 9 (9). CD010216. doi:10.1002/14651858.CD010216.pub3. PMC 6457845. PMID 27622384.
150. ^ Rahman, Muhammad Aziz (30 March 2015). "E-Cigarettes and Smoking Cessation: Evidence from a Systematic Review and Meta-Analysis". PLOS ONE. 10 (3): e0122544. Bibcode:2015PLoSO..1022544R. doi:10.1371/journal.pone.0122544. PMC 4378973. PMID 25822251.
151. Lindson-Hawley, Nicola; Hartmann-Boyce, Jamie; Fanshawe, Thomas R; Begh, Rachna; Farley, Amanda; Lancaster, Tim; Lindson-Hawley, Nicola (2016). "Interventions to reduce harm from continued tobacco use". The Cochrane Database of Systematic Reviews. 10 (12): CD005231. doi:10.1002/14651858.CD005231.pub3. PMC 6463938. PMID 27734465.
152. ^ Khoudigian, S.; Devji, T.; Lytvyn, L.; Campbell, K.; Hopkins, R.; O'Reilly, D. (29 January 2016). "The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis". International Journal of Public Health. 61 (2): 257–267. doi:10.1007/s00038-016-0786-z. ISSN 1661-8556. PMID 26825455. S2CID 22227035.
153. Claire, Ravinder; Chamberlain, Catherine; Davey, Mary-Ann; Cooper, Sue E.; Berlin, Ivan; Leonardi-Bee, Jo; Coleman, Tim (4 March 2020). "Pharmacological interventions for promoting smoking cessation during pregnancy". The Cochrane Database of Systematic Reviews. 2020 (3): CD010078. doi:10.1002/14651858.CD010078.pub3. ISSN 1469-493X. PMC 7059898. PMID 32129504.
154. Lucchiari, Claudio; Masiero, Marianna; Botturi, Andrea; Pravettoni, Gabriella (2016). "Helping patients to reduce tobacco consumption in oncology: a narrative review". SpringerPlus. 5 (1): 1136. doi:10.1186/s40064-016-2798-9. ISSN 2193-1801. PMC 4954805. PMID 27504234.
155. Gentry, Sarah; Forouhi, Nita; Notley, Caitlin (2018). "Are Electronic Cigarettes an Effective Aid to Smoking Cessation or Reduction Among Vulnerable Groups? A Systematic Review of Quantitative and Qualitative Evidence". Nicotine & Tobacco Research. 21 (5): 602–616. doi:10.1093/ntr/nty054. ISSN 1462-2203. PMC 6697178. PMID 29608714.
156. Harrell, PT; Simmons, VN; Correa, JB; Padhya, TA; Brandon, TH (4 June 2014). "Electronic Nicotine Delivery Systems ("E-cigarettes"): Review of Safety and Smoking Cessation Efficacy". Otolaryngology–Head and Neck Surgery. 151 (3): 381–393. doi:10.1177/0194599814536847. PMC 4376316. PMID 24898072.
157. Patnode, Carrie D.; Henderson, Jillian T.; Thompson, Jamie H.; Senger, Caitlyn A.; Fortmann, Stephen P.; Whitlock, Evelyn P. (September 2015). "Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force" (PDF). Annals of Internal Medicine. 163 (8): 608. doi:10.7326/M15-0171. ISSN 0003-4819. PMID 26491759. S2CID 207538340.
158. Farsalinos, Konstantinos; LeHouezec, Jacques (2015). "Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes)". Risk Management and Healthcare Policy. 8: 157–167. doi:10.2147/RMHP.S62116. ISSN 1179-1594. PMC 4598199. PMID 26457058.
159. WHO 2014, p. 10.
160. ^ Brady, Benjamin R.; De La Rosa, Jennifer S.; Nair, Uma S.; Leischow, Scott J. (2019). "Electronic Cigarette Policy Recommendations: A Scoping Review". American Journal of Health Behavior. 43 (1): 88–104. doi:10.5993/AJHB.43.1.8. ISSN 1087-3244. PMID 30522569. S2CID 54566712.
161. ^ Farsalinos, K. E.; Polosa, R. (2014). "Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review". Therapeutic Advances in Drug Safety. 5 (2): 67–86. doi:10.1177/2042098614524430. ISSN 2042-0986. PMC 4110871. PMID 25083263.
162. ^ Smith, L; Brar, K; Srinivasan, K; Enja, M; Lippmann, S (June 2016). "E-cigarettes: How "safe" are they?". J Fam Pract. 65 (6): 380–385. PMID 27474819.
163. Glover, Marewa; Breier, Bernhard H.; Bauld, Linda (2016). "Could Vaping be a New Weapon in the Battle of the Bulge?". Nicotine & Tobacco Research. 19 (12): 1536–1540. doi:10.1093/ntr/ntw278. hdl:1893/26149. ISSN 1462-2203. PMID 27798086. S2CID 3799963.
164. Detailed reference list is located at a separate image page.
165. ^ Cooke, Andrew; Fergeson, Jennifer; Bulkhi, Adeeb; Casale, Thomas B. (2015). "The Electronic Cigarette: The Good, the Bad, and the Ugly". The Journal of Allergy and Clinical Immunology: In Practice. 3 (4): 498–505. doi:10.1016/j.jaip.2015.05.022. ISSN 2213-2198. PMID 26164573.
166. ^ Bekki, Kanae; Uchiyama, Shigehisa; Ohta, Kazushi; Inaba, Yohei; Nakagome, Hideki; Kunugita, Naoki (2014). "Carbonyl Compounds Generated from Electronic Cigarettes". International Journal of Environmental Research and Public Health. 11 (11): 11192–11200. doi:10.3390/ijerph111111192. ISSN 1660-4601. PMC 4245608. PMID 25353061. This article incorporates text by Kanae Bekki, Shigehisa Uchiyama, Kazushi Ohta, Yohei Inaba, Hideki Nakagome and Naoki Kunugita available under the CC BY 4.0 license.
167. ^ McNeill 2015, p. 77.
168. National Academies of Sciences, Engineering, and Medicine (2018), p. 56, Characteristics of E-Cigarette Devices.
169. Rowell, Temperance R; Tarran, Robert (2015). "Will Chronic E-Cigarette Use Cause Lung Disease?". American Journal of Physiology. Lung Cellular and Molecular Physiology. 309 (12): L1398–L1409. doi:10.1152/ajplung.00272.2015. ISSN 1040-0605. PMC 4683316. PMID 26408554.
170. SGUS 2014, p. 115.
171. "Johns Hopkins Finds Thousands of Unknown Chemicals in E-Cigarettes". Johns Hopkins University. Retrieved 24 November 2021.
172. Layden, Jennifer E.; Ghinai, Isaac; Pray, Ian; Kimball, Anne; Layer, Mark; Tenforde, Mark W.; Navon, Livia; Hoots, Brooke; Salvatore, Phillip P.; Elderbrook, Megan; Haupt, Thomas (6 September 2019). "Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report". New England Journal of Medicine. 382 (10): 903–916. doi:10.1056/NEJMoa1911614. PMID 31491072.
173. Blount, Benjamin C.; Karwowski, Mateusz P.; Shields, Peter G.; Morel-Espinosa, Maria; Valentin-Blasini, Liza; Gardner, Michael; Braselton, Martha; Brosius, Christina R.; Caron, Kevin T.; Chambers, David; Corstvet, Joseph (20 December 2019). "Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI". New England Journal of Medicine. 382 (8): 697–705. doi:10.1056/NEJMoa1916433. PMC 7032996. PMID 31860793.
174. Cetinkaya, Pelin Duru; Pazarli Bostan, Pinar; Salepci, Banu; Gorekdilektasli, Asli; Elbek, Osman; Uyanusta Kucuk, Filiz Cagla; Karadogan, Dilek; Arpaz, Seren; Dülger, Seyhan; Atilla Uysal, Mehmet; Uzaslan, Esra; Özge, Cengiz; Kılınç, Oğuz; Dağlı, Elif; Itil, Oya (18 July 2022). "Turkish Thoracic Society's Statement Report on Electronic Cigarettes and Heated Tobacco Products". Turkish Thoracic Journal. 23 (4): 296–301. doi:10.5152/TurkThoracJ.2022.22018. PMC 9361150. PMID 35848438.
175. ^ Kim, Ki-Hyun; Kabir, Ehsanul; Jahan, Shamin Ara (2016). "Review of electronic cigarettes as tobacco cigarette substitutes: their potential human health impact". Journal of Environmental Science and Health, Part C. 34 (4): 262–275. Bibcode:2016JESHC..34..262K. doi:10.1080/10590501.2016.1236604. ISSN 1059-0501. PMID 27635466. S2CID 42660975.
176. ^ Fernández, Esteve; Ballbè, Montse; Sureda, Xisca; Fu, Marcela; Saltó, Esteve; Martínez-Sánchez, Jose M. (2015). "Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study". Current Environmental Health Reports. 2 (4): 423–429. Bibcode:2015CEHR....2..423F. doi:10.1007/s40572-015-0072-x. ISSN 2196-5412. PMID 26452675.
177. ^ Chang, H. (2014). "Research gaps related to the environmental impacts of electronic cigarettes". Tobacco Control. 23 (Supplement 2): ii54–ii58. doi:10.1136/tobaccocontrol-2013-051480. ISSN 0964-4563. PMC 3995274. PMID 24732165.
178. Kaisar, Mohammad Abul; Prasad, Shikha; Liles, Tylor; Cucullo, Luca (2016). "A Decade of e-Cigarettes: Limited Research & Unresolved Safety Concerns". Toxicology. 365: 67–75. Bibcode:2016Toxgy.365...67K. doi:10.1016/j.tox.2016.07.020. ISSN 0300-483X. PMC 4993660. PMID 27477296.
179. ^ "Experts Clear the Air on E-Cigarettes". Columbia University Mailman School of Public Health. 26 January 2018.
180. Kenny, PJ (September 2014). "Genetics of Substance Use Disorders". Dialogues Clin Neurosci. 16 (3): 335–344. doi:10.31887/DCNS.2014.16.3/pkenny. PMC 4214176. PMID 25364284.
181. D'Souza, Manoranjan S. (2015). "Glutamatergic transmission in drug reward: implications for drug addiction". Frontiers in Neuroscience. 9: 404. doi:10.3389/fnins.2015.00404. ISSN 1662-453X. PMC 4633516. PMID 26594139.
182. MacDonald, K; Pappa, K (April 2016). "WHY NOT POT?: A Review of the Brain-based Risks of Cannabis". Innov Clin Neurosci. 13 (3–4): 13–22. PMC 4911936. PMID 27354924.
183. Kishioka, Shiroh; Kiguchi, Norikazu; Kobayashi, Yuka; Saika, Fumihiro (2014). "Nicotine Effects and the Endogenous Opioid System". Journal of Pharmacological Sciences. 125 (2): 117–124. doi:10.1254/jphs.14R03CP. ISSN 1347-8613. PMID 24882143.
184. ^ Hiemstra, Pieter S.; Bals, Robert (2016). "Basic science of electronic cigarettes: assessment in cell culture and in vivo models". Respiratory Research. 17 (1): 127. doi:10.1186/s12931-016-0447-z. ISSN 1465-993X. PMC 5055681. PMID 27717371.
185. Lee, Peter N.; Fariss, Marc W. (2016). "A systematic review of possible serious adverse health effects of nicotine replacement therapy". Archives of Toxicology. 91 (4): 1565–1594. doi:10.1007/s00204-016-1856-y. ISSN 0340-5761. PMC 5364244. PMID 27699443.
186. D'Souza MS; Markou A (2011). "Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments". Addict Sci Clin Pract. 6 (1): 4–16. PMC 3188825. PMID 22003417.
187. ^ Jackson, K.J.; Muldoon, P.P.; De Biasi, M.; Damaj, M.I. (2015). "New mechanisms and perspectives in nicotine withdrawal". Neuropharmacology. 96 (Pt B): 223–234. doi:10.1016/j.neuropharm.2014.11.009. ISSN 0028-3908. PMC 4444410. PMID 25433149.
188. Hadjiconstantinou, Maria; Neff, Norton H. (2011). "Nicotine and endogenous opioids: Neurochemical and pharmacological evidence". Neuropharmacology. 60 (7–8): 1209–1220. doi:10.1016/j.neuropharm.2010.11.010. ISSN 0028-3908. PMID 21108953. S2CID 45539554.
189. ^ Korpi, E. R.; den Hollander, B.; Farooq, U.; Vashchinkina, E.; Rajkumar, R.; Nutt, D. J.; Hyytia, P.; Dawe, G. S. (2015). "Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse". Pharmacological Reviews. 67 (4): 872–1004. doi:10.1124/pr.115.010967. ISSN 1521-0081. PMID 26403687.
190. Chenoweth, Meghan J.; Tyndale, Rachel F. (2017). "Pharmacogenetic Optimization of Smoking Cessation Treatment". Trends in Pharmacological Sciences. 38 (1): 55–66. doi:10.1016/j.tips.2016.09.006. ISSN 0165-6147. PMC 5195866. PMID 27712845.
191. Di Matteo, Vincenzo; Pierucci, Massimo; Di Giovanni, Giuseppe; Benigno, Arcangelo; Esposito, Ennio (2007). "The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction". Current Pharmaceutical Design. 13 (12): 1269–1284. doi:10.2174/138161207780618920. ISSN 1381-6128. PMID 17504235.
192. ^ "Know The Risks: E-Cigarettes & Young People – Addiction". Surgeon General of the United States. 2016. This article incorporates text from this source, which is in the public domain.
193. Richard Beebe; Jeff Myers (19 July 2012). Professional Paramedic, Volume I: Foundations of Paramedic Care. Cengage Learning. pp. 640–. ISBN 978-1-133-71465-1.
194. ^ Drug Therapeutics Bulletin (26 November 2014). "Republished: Nicotine and health". BMJ. 349. 2014.7.0264rep. doi:10.1136/bmj.2014.7.0264rep. ISSN 1756-1833. PMID 25428425. S2CID 45426626.
195. Atta-ur-Rahman; Allen B. Reitz (1 January 2005). Frontiers in Medicinal Chemistry. Bentham Science Publishers. pp. 279–. ISBN 978-1-60805-205-9.
196. Bruijnzeel, Adrie W. (2012). "Tobacco addiction and the dysregulation of brain stress systems". Neuroscience & Biobehavioral Reviews. 36 (5): 1418–1441. doi:10.1016/j.neubiorev.2012.02.015. ISSN 0149-7634. PMC 3340450. PMID 22405889.
197. Alasmari, Fawaz; Al-Rejaie, Salim S.; AlSharari, Shakir D.; Sari, Youssef (2016). "Targeting glutamate homeostasis for potential treatment of nicotine dependence". Brain Research Bulletin. 121: 1–8. doi:10.1016/j.brainresbull.2015.11.010. ISSN 0361-9230. PMC 4783195. PMID 26589642.
198. ^ Uchida, Sae; Hotta, Harumi (2009). "Cerebral Cortical Vasodilatation Mediated by Nicotinic Cholinergic Receptors: Effects of Old Age and of Chronic Nicotine Exposure". Biological & Pharmaceutical Bulletin. 32 (3): 341–344. doi:10.1248/bpb.32.341. ISSN 0918-6158. PMID 19252275.
199. SGUS 2014, p. 111.
200. Laura J. Martin; David Zieve; Isla Ogilvie (7 June 2016). "Nicotine and Tobacco". Medline Plus.
201. ^ "Nicotine". National Institute on Drug Abuse. June 2007. Archived from the original on 11 June 2019. Retrieved 2 June 2019. This article incorporates text from this source, which is in the public domain.
202. Shahab, Lion; Brose, Leonie S.; West, Robert (2013). "Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems". CNS Drugs. 27 (12): 1007–1019. doi:10.1007/s40263-013-0116-4. ISSN 1172-7047. PMID 24114587. S2CID 207486096.
203. Palazzolo, Dominic L. (November 2013). "Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review". Frontiers in Public Health. 1 (56): 56. doi:10.3389/fpubh.2013.00056. PMC 3859972. PMID 24350225.
204. ^ Schroeder, M. J.; Hoffman, A. C. (2014). "Electronic cigarettes and nicotine clinical pharmacology". Tobacco Control. 23 (Supplement 2): ii30–ii35. doi:10.1136/tobaccocontrol-2013-051469. ISSN 0964-4563. PMC 3995273. PMID 24732160.
205. Bold, Krysten W.; Sussman, Steve; O'Malley, Stephanie S.; Grana, Rachel; Foulds, Jonathan; Fishbein, Howard; Krishnan-Sarin, Suchitra (2018). "Measuring E-cigarette dependence: Initial guidance". Addictive Behaviors. 79: 213–218. doi:10.1016/j.addbeh.2017.11.015. ISSN 0306-4603. PMC 5807200. PMID 29174664.
206. McNeill 2018, p. 12.
207. Jenssen, Brian P.; Wilson, Karen M. (2017). "Tobacco Control and Treatment for the Pediatric Clinician: Practice, Policy, and Research Updates". Academic Pediatrics. 17 (3): 233–242. doi:10.1016/j.acap.2016.12.010. ISSN 1876-2859. PMID 28069410.
208. "DrugFacts: Electronic Cigarettes (e-Cigarettes)". National Institute on Drug Abuse. September 2014.
209. Evans, S. E.; Hoffman, A. C. (2014). "Electronic cigarettes: abuse liability, topography and subjective effects". Tobacco Control. 23 (Supplement 2): ii23–ii29. doi:10.1136/tobaccocontrol-2013-051489. ISSN 0964-4563. PMC 3995256. PMID 24732159.
210. Chapman 2015, p. 5.
211. "Teens like different forms of tobacco and nicotine". American Cancer Society. Archived from the original on 20 September 2015.
212. Singh, Tushar; Arrazola, René A.; Corey, Catherine G.; Husten, Corinne G.; Neff, Linda J.; Homa, David M.; King, Brian A. (2016). "Tobacco Use Among Middle and High School Students — United States, 2011–2015". MMWR. Morbidity and Mortality Weekly Report. 65 (14): 361–367. doi:10.15585/mmwr.mm6514a1. ISSN 0149-2195. PMID 27077789.
213. ^ Durmowicz, E. L. (2014). "The impact of electronic cigarettes on the paediatric population". Tobacco Control. 23 (Supplement 2): ii41–ii46. doi:10.1136/tobaccocontrol-2013-051468. ISSN 0964-4563. PMC 3995262. PMID 24732163.
214. ^ "European court: Tougher rules on electronic cigarettes". Business Insider. Associated Press. 4 May 2016. Archived from the original on 2 June 2019. Retrieved 2 June 2019.
215. "Sottera v US Food and Drug Administration". Public Health Law Center. Archived from the original on 23 February 2020. Retrieved 23 February 2020.
216. ^ "FDA's New Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products". United States Food and Drug Administration. 17 August 2017.
217. Gualano, Maria Rosaria; Passi, Stefano; Bert, Fabrizio; La Torre, Giuseppe; Scaioli, Giacomo; Siliquini, Roberta (September 2015). "Electronic cigarettes: assessing the efficacy and the adverse effects through a systematic review of published studies". Journal of Public Health. 37 (3): 488–497. doi:10.1093/pubmed/fdu055. ISSN 1741-3842. PMID 25108741.
218. ^ "Heart and Stroke Foundation: E-cigarettes in Canada". Heart and Stroke Foundation. September 2014. Archived from the original on 6 October 2014.
219. ^ "WHO Right to Call for E-Cigarette Regulation". World Lung Federation. 26 August 2014.
220. Bullen, Chris; Knight-West, Oliver (August 2016). "E-cigarettes for the management of nicotine addiction". Substance Abuse and Rehabilitation. 7: 111–118. doi:10.2147/SAR.S94264. ISSN 1179-8467. PMC 4993405. PMID 27574480.
221. "FCA Policy briefing Electronic Nicotine Delivery Systems" (PDF). Framework Convention Alliance on Tobacco Control. 13–18 October 2014. Archived from the original (PDF) on 6 March 2016. Retrieved 2 March 2016.
222. World Health Organization (2019). "Offer help to quit tobacco use". WHO report on the global tobacco epidemic, 2019 (Report). World Health Organization. ISBN 9789241516204.
223. WHO Study Group on Tobacco Product Regulation (2015). Report on the Scientific Basis of Tobacco Product Regulation: Fifth Report of a WHO Study Group (Report). WHO Technical Report Series. Vol. 989. Geneva: World Health Organization. ISBN 9789240693807. Retrieved 14 November 2022.
224. ^ Farber, Harold J.; Conrado Pacheco Gallego, Manuel; Galiatsatos, Panagis; Folan, Patricia; Lamphere, Thomas; Pakhale, Smita (1 April 2021). "Harms of Electronic Cigarettes: What the Healthcare Provider Needs to Know". Annals of the American Thoracic Society. 18 (4): 567–572. doi:10.1513/AnnalsATS.202009-1113CME. ISSN 2329-6933. PMID 33284731. S2CID 227948907.
225. Royal College of Physicians. "Nicotine Without Smoke -- Tobacco Harm Reduction". p. 125. Retrieved 30 September 2020. Use of nicotine alone, in the doses used by smokers, represents little if any hazard to the user.
226. "E-cigarettes: an emerging public health consensus". UK: Public Health England. 15 September 2015.
227. "Position Statement on Electronic Cigarettes". American Cancer Society. 19 November 2019. Retrieved 15 November 2022.
228. ^ "Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products". Federal Register. 81 (90). United States Food and Drug Administration: 28974–29106. 10 May 2016.
229. Pisinger, Charlotta; Dagli, Elif; Filippidis, Filippos T.; Hedman, Linnea; Janson, Christer; Loukides, Stelios; Ravara, Sofia; Saraiva, Isabel; Vestbo, Jørgen (December 2019). "ERS and tobacco harm reduction". European Respiratory Journal. 54 (6): 1902009. doi:10.1183/13993003.02009-2019. hdl:10044/1/75851. PMID 31801824. S2CID 208642811.
230. CDC's Office on Smoking and Health (3 August 2021). "Smoking and Tobacco Use; Electronic Cigarettes". Centers for Disease Control and Prevention.
231. ^ Dutra, Lauren M; Grana, Rachel; Glantz, Stanton A (2016). "Philip Morris research on precursors to the modern e-cigarette since 1990". Tobacco Control. 26 (e2): tobaccocontrol–2016–053406. doi:10.1136/tobaccocontrol-2016-053406. ISSN 0964-4563. PMC 5432409. PMID 27852893.
232. Prashant Sharma (6 November 2015). "A Modern Device with an Illustrious History". TechPluto.
233. "A Historical Timeline of Electronic Cigarettes". The Consumer Advocates for Smoke-free Alternatives Association. 2016.
234. ^ Farsalinos, Konstantinos E.; Gillman, I. Gene; Hecht, Stephen S.; Polosa, Riccardo; Thornburg, Jonathan (16 November 2016). Analytical Assessment of e-Cigarettes: From Contents to Chemical and Particle Exposure Profiles. Elsevier Science. p. 1. ISBN 978-0-12-811242-7.
235. Noah Charney (7 December 2014). "America's vaping revolution: How suspicious should we really be of the e-cigarette craze?". Salon.
236. "US Patent 3200819. Smokeless non-tobacco cigarette". 17 August 1965. Archived from the original on 12 October 2011.
237. ^ Mary Bellis (2015). "Who Invented Electronic Cigarettes?". About.com. Archived from the original on 1 August 2022. Retrieved 21 September 2013.
238. ^ P.H. (17 March 2014). "A case of the vapers". Economist Group.
239. Julie Beck (13 June 2014). "Schrödinger's Cigarette: Is Electronic Safer?". The Atlantic.
240. Millstein, Seth (25 April 2009). "The Push to Ban E-Cigarettes: Where's the Proof?". TimeLine. Archived from the original on 2 July 2015.
241. "Electronic Cigarette Sales on the Rise". WalesOnline. 24 August 2011.
242. Dunworth, James (June 2014). "Vaping 1970's Style: An Interview with One of the Pioneers". Ashtray Blog. Retrieved 27 June 2021.
243. MCGonegal, Matthew (November 2019). "Can I rip your Juul?" (Bsc). University of Oregon. Retrieved 27 June 2021.
244. "Company sniffs profits from a smokeless cigarette". Chicago Tribune. 27 May 1986. Retrieved 27 June 2021.
245. "FDA's Brief in Opposition to Motion for Preliminary Injunction". Food and Drug Administration. 11 May 2009.
246. Chowdhury, Azim; Jockel, Samuel (October–November 2018). "Spotlight on Tobacco | Future Developments in the Regulation of Electronic Nicotine Delivery Systems: Potential Over-the-Counter Pathway". Update magazine. Food and Drug Law Institute. Retrieved 27 June 2021.
247. Coffee, Brenda (22 December 2018). "A deadly addicting lie". 1010ParkPlace. Retrieved 27 June 2021.
248. ^ Barbara Demick (25 April 2009). "A high-tech approach to getting a nicotine fix". Los Angeles Times.
249. ^ Sridi, Nicolas (10 July 2013). "I was sure that the electronic cigarette would be welcomed with open arms". Sciences et Avenir.
250. ^ Tom Hancock (1 October 2013). "China's e-cigarette inventor fights for financial rewards". Fox News Channel.
251. Spencer, Ben; Calver, Tom (30 October 2021). "Vape nation: how did Britain end up so hooked on e‑cigarettes?". The Times.
252. "E-cigarettes attracting attention — and scrutiny". NBCNews.com. Associated Press. 27 February 2009. Archived from the original on 6 March 2016.
253. Tom Hancock (4 October 2013). "Chinese e-cigarette inventor fights for royalties". The Japan Times. Archived from the original on 1 August 2022. Retrieved 1 June 2015.
254. "Electronic Atomization Cigarette". Worldwide.espacenet.com. 22 November 2007.
255. ^ Staff (21 August 2013). "Dragonite Sells E-Vapor Business To ITG". Convenient Store Decisions.
256. ^ Garner, Charles; Stevens, Robert (February 2014). "A Brief Description of History, Operation and Regulation" (PDF). Coresta. Archived from the original (PDF) on 3 March 2016.
257. ^ Mike K (9 June 2015). "What Does The Future Hold For Vaping Technology?". Steve K's Vaping World.
258. Annabel Denham (10 June 2013). "Brothers who took a punt on a new market". CityAM. Archived from the original on 7 May 2016.
259. ^ Michael Grothaus (1 October 2014). "Trading addictions: the inside story of the e-cig modding scene". Engadget.
260. ^ Mangan, Dan (15 July 2014). "Feeling blu? E-cig company spun off in major tobacco deal". CNBC.
261. ^ Crook, Jordan (20 December 2018). "Juul Labs gets $12.8 billion investment from Marlboro Maker Altria Group". TechCrunch.
262. Younkman, Jon (12 November 2019). "Altria Has a Juul in the Rough". The Motley Fool.
263. ^ "Japan Tobacco's Global Ambitions Lead to Logic Acquisition". Convenience Store News. 30 April 2015.
264. Akam, Simon (27 May 2015). "Big Tobacco fights back: how the cigarette kings bought the vaping industry". Newsweek.
265. "Kodak moment". The Economist. 28 September 2013.
266. ^ Mike Esterl (3 February 2014). "Altria Expands in E-Cigarettes With Green Smoke". The Wall Street Journal.
267. Brian Montopoli (11 June 2013). "Tobacco companies bet on electronic cigarettes". CBS News.
268. ^ Daniel Nasaw (5 December 2012). "Electronic cigarettes challenge anti-smoking efforts". BBC News.
269. ^ Sanchez Manning (29 July 2013). "British American Tobacco enters electronic cigarette market in Britain with the 'Vype'". The Independent.
270. Gustafsson, Katarina (2 September 2013). "Imperial Tobacco Agrees to Acquire Dragonite's E-Cigarette Unit". Bloomberg News.
271. Arcieri, Katie (1 October 2013). "Lorillard acquires British e-cig maker for $48.6M". Triad Business Journal.
272. "Lorillard to Rebrand SKYCIG as blu eCigs". Convenience Store News. 27 March 2014.
273. "RPT-Fitch: Altria Green Smoke Buy Highlights Industry e-Cig Interest". Reuters. 5 February 2014. Retrieved 13 November 2022.
274. Egan, Matt (9 January 2016). "Altria Bolsters E-Cigarette Business With $110M Buy of Green Smoke". FOXBusiness. Retrieved 13 November 2022.
275. Gideon Spanier (26 June 2014). "Philip Morris buys e-cigarette maker Nicocigs as it warns of falling profits". The Independent.
276. "Using e-cigarettes to stop smoking". nhs.uk. 24 November 2021. Retrieved 7 April 2022.
277. (ASH), Action on Smoking and Health (June 2021). "Use of e-cigarettes (vapes) among adults in Great Britain. 2021" (PDF). Use of E-cigarettes (Vapes) Among Adults in Great Britain. 2021.
278. Thomas, Tobi; Health, Tobi Thomas (11 August 2024). "Number of UK adults who vape reaches record level, report finds". The Guardian. ISSN 0261-3077. Retrieved 22 August 2024.
279. ^ Couts, Andrew (13 May 2013). "Inside the world of vapers, the subculture that might save smokers' lives". Digital Trends.
280. Park, Andy (26 August 2013). "The Feed: The subculture around e-cigarettes". SBS World News.
281. Barbeau, Amanda M; Burda, Jennifer; Siegel, Michael (2013). "Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach". Addiction Science & Clinical Practice. 8 (1): 5. doi:10.1186/1940-0640-8-5. ISSN 1940-0640. PMC 3599549. PMID 23497603.
282. ^ Eric Larson (25 January 2014). "Pimp My Vape: The Rise of E-Cigarette Hackers". Mashable.
283. Molly Osberg (25 February 2014). "CVape life: welcome to the weird world of e-cig evangelists". The Verge.
284. Sanford Z; Goebel L (2014). "E-cigarettes: an up to date review and discussion of the controversy". W V Med J. 110 (4): 10–5. PMID 25322582.
285. ^ McKee, M. (2014). "Electronic cigarettes: peering through the smokescreen". Postgraduate Medical Journal. 90 (1069): 607–609. doi:10.1136/postgradmedj-2014-133029. ISSN 0032-5473. PMID 25294933.
286. Tom Gara (14 April 2014). "Are E-Cigarettes Losing Ground in the Vapor Market?". The Wall Street Journal.
287. Sottile, Leah (8 October 2014). "The Right to Vape". The Atlantic.
288. Jacobs, Emma; Robinson, Duncan (17 April 2014). "E-cigarettes: no smoke without fear". FT Magazine.
289. Gavin Haynes (22 April 2015). "Daft vapers: the competitive world of e-cigarette smoking". The Guardian.
290. Mike Esterl (29 May 2014). "'Vaporizers' Are the New Draw in E-Cigarettes". The Wall Street Journal.
291. Staff (13 February 2014). "Generation V E-Cigarettes and Vape Bar aims to convert smokers to e-cigarettes". Daily Nebraskan.
292. Neil Nisperos (4 September 2014). "Vaping convention coming to Ontario Convention Center Friday". Inland Valley Daily Bulletin.
293. Mary Plass (29 January 2014). "The Cloud Chasers". Vape News Magazine.
294. Dominique Mosbergen (5 August 2014). "This Man Is An Athlete In The Sport Of 'Cloud Chasing'". HuffPost.
295. ^ Sean Cooper (23 May 2014). "What you need to know about vaporizers". Engadget.
296. Victoria Bekiempis (1 April 2015). "Veteran E-Cigarette Users Fret 'Cloud Chasers' Give Them a Bad Name". Newsweek.
297. Fallon, Claire (19 November 2014). "'Vape' Is Oxford Dictionaries' Word Of The Year". HuffPost.
298. Etter, J. F.; Bullen, C.; Flouris, A. D.; Laugesen, M.; Eissenberg, T. (May 2011). "Electronic nicotine delivery systems: a research agenda". Tobacco Control. 20 (3): 243–8. doi:10.1136/tc.2010.042168. PMC 3215262. PMID 21415064.
299. Tabuchi, Takahiro; Gallus, Silvano; Shinozaki, Tomohiro; Nakaya, Tomoki; Kunugita, Naoki; Colwell, Brian (2018). "Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol". Tobacco Control. 27 (e1): e25–e33. doi:10.1136/tobaccocontrol-2017-053947. ISSN 0964-4563. PMC 6073918. PMID 29248896.
300. ^ Beard, Emma; Shahab, Lion; Cummings, Damian M.; Michie, Susan; West, Robert (2016). "New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?" (PDF). CNS Drugs. 30 (10): 951–83. doi:10.1007/s40263-016-0362-3. ISSN 1172-7047. PMID 27421270. S2CID 40411008.
301. McNeill 2018, p. 46.
302. Barnaby Page (5 March 2015). "World's law-makers favour basing e-cig rules on tobacco". ECigIntelligence. Tamarind Media Limited.
303. Lempert, Lauren K; Grana, Rachel; Glantz, Stanton A (2016). "The importance of product definitions in US e-cigarette laws and regulations". Tobacco Control. 25 (e1): e44–e51. doi:10.1136/tobaccocontrol-2014-051913. ISSN 0964-4563. PMC 4466213. PMID 25512432.
304. ^ "U.S. Department of Transportation Explicitly Bans the Use of Electronic Cigarettes on Commercial Flights". United States Department of Transportation. 2 March 2016.
305. "What the RCP thinks about tobacco". UK: Royal College of Physicians. 1 February 2018. pp. 1–2.
306. Robertson, Adi (18 September 2019). "India bans e-cigarette sales and says there's an 'epidemic' of kids vaping". The Verge.
307. Sienuic, Kat (29 September 2014). "Public health officers tackle hazy issue of e-cigarettes". The Globe and Mail.
308. "Vaping, e-cigarettes to be regulated by Health Canada". CBC News. 22 November 2016.
309. Kadowaki, Joy; Vuolo, Mike; Kelly, Brian C. (2015). "A review of the current geographic distribution of and debate surrounding electronic cigarette clean air regulations in the United States". Health & Place. 31: 75–82. doi:10.1016/j.healthplace.2014.11.003. ISSN 1353-8292. PMC 4305454. PMID 25463920.
310. "E-cigarettes to be stubbed out for under-18s". BBC News. 26 January 2014.
311. Francesca Washtell (5 May 2016). "EU Tobacco Products Directive chokes off the UK's e-cigarette and vaping market". City A.M.
312. Zainol Abidin, Najihah; Zainal Abidin, Emilia; Zulkifli, Aziemah; Karuppiah, Karmegam; Syed Ismail, Sharifah Norkhadijah; Amer Nordin, Amer Siddiq (2017). "Electronic cigarettes and indoor air quality: a review of studies using human volunteers" (PDF). Reviews on Environmental Health. 32 (3): 235–244. doi:10.1515/reveh-2016-0059. ISSN 2191-0308. PMID 28107173. S2CID 6885414.
313. McNeill 2018, p. 39.
314. Ashitha Nagesh (10 July 2013). "Anger over tobacco lobbyists as Europe nears new rules on e-cigarettes". Euronews.
315. ^ "The Facts on the FDA's New Tobacco Rule". United States Food and Drug Administration. 2 May 2017.
316. "Summary of Federal Rules for Tobacco Retailers". United States Food and Drug Administration. 23 August 2017.
317. "Extension of Certain Tobacco Product Compliance Deadlines Related to the Final Deeming Rule (Revised)". United States Food and Drug Administration. 4 August 2017.
318. "Guidance: Extension of Certain Tobacco Product Compliance Deadlines Related to the Final Deeming Rule (Revised*)" (PDF). United States Food and Drug Administration. August 2017.
319. Perrone, Matthew (28 March 2018). "Lawsuit Challenges FDA Delay of E-cigarette Review". Drug Discovery & Development. Associated Press.
320. Eric Lipton (2 September 2016). "A Lobbyist Wrote the Bill. Will the Tobacco Industry Win Its E-Cigarette Fight?". The New York Times.
321. "Questions & Answers: New rules for tobacco products". European Commission. 26 February 2014.
322. "Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products". Federal Register. 79 (80). United States Food and Drug Administration: 23142–23207. 25 April 2014.
323. Sabrina Tavernise (24 April 2014). "F.D.A. Will Propose New Regulations for E-Cigarettes". The New York Times.
324. Crowley, Ryan A. (2015). "Electronic Nicotine Delivery Systems: Executive Summary of a Policy Position Paper From the American College of Physicians". Annals of Internal Medicine. 162 (8): 583–4. doi:10.7326/M14-2481. ISSN 0003-4819. PMID 25894027.
325. "Alternative Nicotine Products – Electronic Cigarettes". National Conference of State Legislatures. 3 March 2017.
326. "Vaping Law FAQ - Vaping Regulations Explained | Shosha NZ". www.shosha.co.nz. Archived from the original on 25 June 2021. Retrieved 25 June 2021.
327. Cervellin, Gianfranco; Borghi, Loris; Mattiuzzi, Camilla; Meschi, Tiziana; Favaloro, Emmanuel; Lippi, Giuseppe (2013). "E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism". Seminars in Thrombosis and Hemostasis. 40 (1): 060–065. doi:10.1055/s-0033-1363468. ISSN 0094-6176. PMID 24343348.
328. Maloney, Erin K.; Cappella, Joseph N. (2015). "Does Vaping in E-Cigarette Advertisements Affect Tobacco Smoking Urge, Intentions, and Perceptions in Daily, Intermittent, and Former Smokers?". Health Communication. 31 (1): 1–10. doi:10.1080/10410236.2014.993496. ISSN 1041-0236. PMID 25758192. S2CID 31328176.
329. ^ "California Is Forcing Smokers To Buy More Dangerous Products". 6 May 2022.
330. "Vaping 95% less harmful than smoking". August 2015.
331. "San Francisco's Top Economist Confirms Vape Ban Means More Smoking". 15 July 2019.
332. Maloney, Jennifer (22 June 2022). "FDA to Order Juul E-Cigarettes Off U.S. Market". Wall Street Journal.
333. "Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom". 18 May 2021.
334. "Mandating Low-Nicotine Cigarettes Could Make Smoking More Dangerous". 22 June 2022.
335. ^ "Electronic Cigarette Fires and Explosions in the United States 2009-2016" (PDF).
336. ^ "E-Cigarette Fire Risks and Reported Incidents" (PDF).
337. Crotty LE, Alexander; Vyas, A; Schraufnagel, DE; Malhotra, A (2015). "Electronic cigarettes: the new face of nicotine delivery and addiction". Journal of Thoracic Disease. 7 (8): E248–E251. doi:10.3978/j.issn.2072-1439.2015.07.37. PMC 4561260. PMID 26380791.
338. "Position Statement Electronic Cigarettes". Cancer Council Australia; National Heart Foundation of Australia. 2014.
339. ^ Rinkoo, ArvindVashishta; Kaur, Jagdish (2017). "Getting real with the upcoming challenge of electronic nicotine delivery systems: The way forward for the South-East Asia region". Indian Journal of Public Health. 61 (5): S7–S11. doi:10.4103/ijph.IJPH_240_17. ISSN 0019-557X. PMID 28928312.
340. ^ McCausland, Kahlia; Maycock, Bruce; Jancey, Jonine (2017). "The messages presented in online electronic cigarette promotions and discussions: a scoping review protocol". BMJ Open. 7 (11): e018633. doi:10.1136/bmjopen-2017-018633. ISSN 2044-6055. PMC 5695349. PMID 29122804.
341. ^ Chapman 2015, p. 7.
342. Collins, Lauren; Glasser, Allison M; Abudayyeh, Haneen; Pearson, Jennifer L; Villanti, Andrea C (2018). "E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information". Nicotine & Tobacco Research. 21 (1): 14–24. doi:10.1093/ntr/ntx284. ISSN 1462-2203. PMC 6610165. PMID 29315420.
343. Kalkhoran, Sara; Glantz, Stanton A (2016). "E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis". The Lancet Respiratory Medicine. 4 (2): 116–128. doi:10.1016/S2213-2600(15)00521-4. ISSN 2213-2600. PMC 4752870. PMID 26776875.
344. Wasowicz, Adam; Feleszko, Wojciech; Goniewicz, Maciej L (2015). "E-Cigarette use among children and young people: the need for regulation". Expert Rev Respir Med. 9 (5): 1–3. doi:10.1586/17476348.2015.1077120. PMID 26290119. S2CID 207206915.
345. ^ Grana, Rachel A.; Ling, Pamela M. (2014). ""Smoking revolution": a content analysis of electronic cigarette retail websites". Am J Prev Med. 46 (4): 395–403. doi:10.1016/j.amepre.2013.12.010. PMC 3989286. PMID 24650842.
346. Bauld 2014, p. 11.
347. ^ Duke, J. C.; Lee, Y. O.; Kim, A. E.; Watson, K. A.; Arnold, K. Y.; Nonnemaker, J. M.; Porter, L. (2014). "Exposure to Electronic Cigarette Television Advertisements Among Youth and Young Adults". Pediatrics. 134 (1): e29–e36. doi:10.1542/peds.2014-0269. PMID 24918224.
348. "E-cigarette Ads and Youth". Centers for Disease Control and Prevention. 5 January 2016. This article incorporates text from this source, which is in the public domain.
349. Payne, JD; Orellana-Barrios, M; Medrano-Juarez, R; Buscemi, D; Nugent, K (2016). "Electronic cigarettes in the media". Proc (Bayl Univ Med Cent). 29 (3): 280–3. doi:10.1080/08998280.2016.11929436. PMC 4900769. PMID 27365871.
350. Bryan, Christiansen (31 October 2014). Handbook of Research on Global Business Opportunities. IGI Global. pp. 411–. ISBN 978-1-4666-6552-1.
351. "E-cigarettes and Lung Health". American Lung Association. 2015. Archived from the original on 4 October 2015.
352. "Myths and Facts About E-cigarettes". American Lung Association. 2015. Archived from the original on 4 December 2015.
353. Liang, Yunji; Zheng, Xiaolong; Dajun Zheng, Daniel; Zhou, Xingshe (22 January 2016). Zheng, Xiaolong; Dajun Zeng, Daniel; Chen, Hsinchun; Leischow, Scott J. (eds.). Impact of Flavor on Electronic Cigarette Marketing in Social Media. Smart Health: International Conference, ICSH 2015. Phoenix, AZ, USA: Springer. p. 283. ISBN 978-3-319-29175-8.
354. ^ Heydari, Gholamreza; Ahmady, ArezooEbn; Chamyani, Fahimeh; Masjedi, Mohammadreza; Fadaizadeh, Lida (2017). "Electronic cigarette, effective or harmful for quitting smoking and respiratory health: A quantitative review papers". Lung India. 34 (1): 25–28. doi:10.4103/0970-2113.197119. ISSN 0970-2113. PMC 5234193. PMID 28144056.
355. Schivo, Michael; Avdalovic, Mark V.; Murin, Susan (February 2014). "Non-Cigarette Tobacco and the Lung". Clinical Reviews in Allergy & Immunology. 46 (1): 34–53. doi:10.1007/s12016-013-8372-0. ISSN 1080-0549. PMID 23673789. S2CID 23626872.
356. ^ Verhaegen, A.; Van Gaal, L. (2017). "Do E-cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future". Obesity Reviews. 18 (10): 1136–1146. doi:10.1111/obr.12568. ISSN 1467-7881. PMID 28660671. S2CID 29298086.
357. ^ Mickle, Tripp (17 November 2015). "E-Cigarette Sales Rapidly Lose Steam". The Wall Street Journal.
358. West, Robert; Beard, Emma; Brown, Jamie (9 January 2018). "Electronic cigarettes in England - latest trends (STS140122)". Smoking in England. p. 28. Archived from the original on 18 December 2015. Retrieved 6 December 2015.
359. Born, H.; Persky, M.; Kraus, D. H.; Peng, R.; Amin, M. R.; Branski, R. C. (2015). "Electronic Cigarettes: A Primer for Clinicians". Otolaryngology–Head and Neck Surgery. 153 (1): 5–14. doi:10.1177/0194599815585752. ISSN 0194-5998. PMID 26002957. S2CID 10199442.
360. Peter Evans (20 February 2015). "E-Cigarette Makers Face Rise of Counterfeits". The Wall Street Journal.
361. Jones, Lora (15 September 2019). "Vaping: How popular are e-cigarettes? - Spending on e-cigarettes is growing". BBC News.
362. Chun, Lauren F; Moazed, Farzad; Calfee, Carolyn S; Matthay, Michael A.; Gotts, Jeffrey Earl (2017). "Pulmonary Toxicity of E-cigarettes". American Journal of Physiology. Lung Cellular and Molecular Physiology. 313 (2): L193–L206. doi:10.1152/ajplung.00071.2017. ISSN 1040-0605. PMC 5582932. PMID 28522559.
363. Meera Senthilingam (23 March 2015). "E-cigarettes: Helping smokers quit, or fueling a new addiction?". CNN.
364. Jourdan, Adam (25 May 2014). ""Vaping" a slow burner in China, world's maker of e-cigarettes". Reuters.
365. Liao, Allen (1 September 2015). "Chinese E-cigarette Makers Shift to Domestic Markets". Tobacco Asia.
366. Kessel, Jonah M. (13 December 2014). "China's E-Cigarette Boom". The New York Times.
367. ^ Yao Min-G (30 May 2015). "The e-cigarette is taking off in nation that invented it". Shanghai Daily.
368. Richard Craver (29 May 2015). "Vuse overwhelming e-cig competition". Winston-Salem Journal.
369. ^ Melissa Vonder Haar (28 May 2014). "Nielsen: Electronic Cigarette Dollar Sales Decline". CSP Magazine.
370. Mickle, Tripp (7 July 2015). "FDA Cloud Hangs Over Vape Shops". The Wall Street Journal.
371. Koebler, Jason (25 September 2014). "Big Tobacco Has Officially Lost Its Hold on the E-Cigarette Market". Motherboard.
372. Esterl, Mike (26 August 2014). "Big Tobacco's E-Cigarette Push Gets a Reality Check". The Wall Street Journal.
373. Das, Smita; Prochaska, Judith J. (2017). "Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders". Expert Review of Respiratory Medicine. 11 (10): 841–850. doi:10.1080/17476348.2017.1361823. ISSN 1747-6348. PMC 5790168. PMID 28756728.
374. ^ Gurdus, Elizabeth (23 April 2018). "Cramer: Vaping is decimating the cigarette industry—and it could get even worse". CNBC.
375. "Ban on flavored vapes could lead to loss of 150,000 jobs, $8.4 billion sales hit: report". Reuters. 22 November 2019.
376. Richtel, Matt; Kaplan, Sheila (27 August 2018). "Did Juul Lure Teenagers and Get 'Customers for Life'?". The New York Times.
377. ^ Will Yakowicz (10 June 2015). "This Silicon Valley Company Just Raised $47 Million to Smoke Cigarette Makers". Inc.
378. ^ Craver, Richard (25 August 2018). "Juul expands e-cig market share gap with Reynolds' Vuse". Winston-Salem Journal.
379. "JUUL copycats are flooding the e-cigarette market". Truth Initiative. 8 August 2018.
380. Yuen, Jenny (4 July 2015). "'Wild West' for e-cigarette use in Canada, critic says". Toronto Sun.
381. Aedan Helmer (6 April 2014). "E-cig retailers stand up to Health Canada". Ottawa Sun.
382. Hammond, D; White, CM; Czoli, CD; Martin, CL; Magennis, P; Shiplo, S (9 October 2015). "Retail availability and marketing of electronic cigarettes in Canada" (PDF). Canadian Journal of Public Health. 106 (6): e408–12. doi:10.17269/cjph.106.5105. PMC 6972063. PMID 26680433.
383. Hiscock, Rosemary; Branston, J Robert; McNeill, Ann; Hitchman, Sara C; Partos, Timea R; Gilmore, Anna B (2017). "Tobacco industry strategies undermine government tax policy: evidence from commercial data". Tobacco Control. 27 (5): tobaccocontrol–2017–053891. doi:10.1136/tobaccocontrol-2017-053891. ISSN 0964-4563. PMC 6109235. PMID 28993519. This article incorporates text by Rosemary Hiscock, J Robert Branston, Ann McNeill, Sara C Hitchman, Timea R Partos, Anna B Gilmore available under the CC BY 4.0 license.
384. ^ McNeill 2015, p. 15.
385. ^ Lastennet, Vincent (7 February 2016). "Cigarettes électroniques. Le marché de la vape en deux cartes". Le Télégramme.
386. "Thuốc lá điện tử, nung nóng độc hại, vì sao có sức hút lớn với giới trẻ Việt Nam? - Tin tổng hợp - Cổng thông tin Bộ Y tế". moh.gov.vn. Retrieved 15 December 2023.
387. Võ, Thu. "5 năm, tỷ lệ hút thuốc lá điện tử ở cả nam và nữ tại Việt Nam tăng 18 lần". VietNamNet News (in Vietnamese). Retrieved 15 December 2023.
388. "Tỷ lệ dùng thuốc lá điện tử ở nhóm 13-15 tuổi là 3,5%". Báo Tuổi Trẻ Thủ Đô (in Vietnamese). Retrieved 15 December 2023.
389. Lê, Nga. "Học sinh 13-15 tuổi hút thuốc lá điện tử tăng". vnexpress.net (in Vietnamese). Retrieved 15 December 2023.
390. VnExpress. "Học sinh 13-15 tuổi hút thuốc lá điện tử tăng". baoquangninh.vn (in Vietnamese). Retrieved 15 December 2023.
391. "Tổn thất kinh tế toàn cầu do thuốc lá gây ra mỗi năm là 1.400 tỷ USD". Báo điện tử VTC News (in Vietnamese). 14 November 2023. Retrieved 15 December 2023.
392. "Đề xuất cấm lưu hành thuốc lá điện tử tại Việt Nam". dangcongsan.vn. Retrieved 15 December 2023.
393. "Gần 97% bệnh nhân ung thư phổi có hút thuốc lá". 23 November 2023. Retrieved 15 December 2023.
394. Phương, Thảo. "Sớm "chốt" giải pháp kiểm soát thuốc lá điện tử". Báo Lao động thủ đô (in Vietnamese). Retrieved 15 December 2023.
395. "Vapor Store". Báo Nhân Dân điện tử (in Vietnamese). 24 October 2023. Retrieved 15 December 2023.
396. "Ưu tiên hỗ trợ Việt Nam thực hiện các mục tiêu của Chiến lược Quốc gia về phòng chống tác hại thuốc lá". 31 October 2023. Retrieved 15 December 2023.
397. Theo, TTXVN (29 May 2015). "Kiểm soát thuốc lá tại Việt Nam: Vẫn nhiều thách thức". Retrieved 15 December 2023.
398. "Cần sớm quản lý đồng thời thuốc lá điện tử và thuốc lá làm nóng". 26 October 2023. Retrieved 15 December 2023.
399. ^ Howard, Brian Clark (11 April 2012). "Cigarettes vs. e-Cigarettes: Which Is Less Environmentally Harmful?". National Geographic. Archived from the original on 24 March 2015.
400. Mock, Jeremiah (2019). "Notes from the Field: Environmental Contamination from E-cigarette, Cigarette, Cigar, and Cannabis Products at 12 High Schools — San Francisco Bay Area, 2018–2019". MMWR Morb Mortal Wkly Rep. 68 (40): 897–899. doi:10.15585/mmwr.mm6840a4. PMC 6788397. PMID 31600185.
401. Davey, James (15 July 2023). "UK councils call for ban on disposable vapes by 2024". Reuters. Retrieved 24 July 2023.
402. ^ Giroud, Christian; de Cesare, Mariangela; Berthet, Aurélie; Varlet, Vincent; Concha-Lozano, Nicolas; Favrat, Bernard (2015). "E-Cigarettes: A Review of New Trends in Cannabis Use". International Journal of Environmental Research and Public Health. 12 (8): 9988–10008. doi:10.3390/ijerph120809988. ISSN 1660-4601. PMC 4555324. PMID 26308021. This article incorporates text by Christian Giroud, Mariangela de Cesare, Aurélie Berthet, Vincent Varlet, Nicolas Concha-Lozano, and Bernard Favrat available under the CC BY 4.0 license.
403. "BAT unit to market nicotine inhaler". Tobacco Journal International. 7 June 2011.
404. Mark Odell (12 September 2014). "British American Tobacco nicotine inhaler wins regulatory approval". Financial Times.
405. Michael Felberbaum (26 May 2011). "Philip Morris Int'l buys rights to nicotine system". The Boston Globe. Associated Press.
406. "New smoking cessation therapy proves promising". Esciencenews. 27 February 2010.
407. ^ National Academies of Sciences, Engineering, and Medicine (2018), p. 96, Nicotine Salts.
408. Taiga Uranaka; Ritsuko Shimizu (29 March 2016). "Big Tobacco Is Starting To Cash In On Vaping". HuffPost. Reuters.
409. Li, Gerard; Saad, Sonia; Oliver, Brian; Chen, Hui (2018). "Heat or Burn? Impacts of Intrauterine Tobacco Smoke and E-Cigarette Vapor Exposure on the Offspring's Health Outcome". Toxics. 6 (3): 43. doi:10.3390/toxics6030043. ISSN 2305-6304. PMC 6160993. PMID 30071638. This article incorporates text by Gerard Li, Sonia Saad, Brian G. Oliver, and Hui Chen available under the CC BY 4.0 license.
410. Michael Felberbaum (26 June 2014). "Philip Morris Int'l to sell Marlboro Heatsticks". Salon Media Group. Associated Press. Archived from the original on 28 June 2014. Retrieved 2 June 2019.
411. Tabuchi, Takahiro; Kiyohara, Kosuke; Hoshino, Takahiro; Bekki, Kanae; Inaba, Yohei; Kunugita, Naoki (2016). "Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan". Addiction. 111 (4): 706–713. doi:10.1111/add.13231. ISSN 0965-2140. PMID 26566956.
412. ^ "New Vaporizing Technology, qmos, set to Revolutionize Vaping and E-Cigarette Industries". Yahoo! Finance. PR Newswire. 2 December 2016.
413. Brad Stone (21 November 2013). "Ploom's E-Cigarettes and Vaporizers Use Real Tobacco". Bloomberg Businessweek.
414. Melissa Vonder Haar (11 March 2015). "PAX Labs CEO Teases 'Fundamentally Different' E-Cigarette". CSP Magazine. Archived from the original on 19 April 2016.
415. Crook, Jordan (8 February 2018). "PAX Labs brings on Bharat Vasan as new CEO". TechCrunch.
416. ^ Tuinstra, Taco (16 December 2014). "Certified organic e-liquids being launched by VTM". Tobacco Reporter.
417. O'Connell, Thomas (9 July 2013). "US8479747B2 - Method for preparing tobacco extract for electronic smoking devices". Google Patents.
418. Tuinstra, Taco (26 January 2016). "JT announces launch of next-generation Ploom". Tobacco Reporter.
419. Rossel, Stefanie (1 July 2016). "Blending nature and technology". Tobacco Reporter.
420. Chambers, Sam (3 February 2017). "Japan Tobacco Sees No Quick Fix for Heat-Not-Burn Shortage". Bloomberg News.
421. "BAT finds strong Japan demand for its Glo smokeless tobacco device". The Japan Times. Reuters. 22 March 2017.
422. "British American Says 2017 Trading in Line With Expectations". The New York Times. Reuters. 26 April 2017.
423. Uranaka, Taiga; Sarkar, Himani (30 May 2017). "British American Tobacco will expand sales of its "glo" tobacco-heating device to Tokyo and Osaka from July". Reuters.
424. ANI (6 March 2016). "Now, 'safer' e-cigarette with tobacco flavour, less harmful smoke". Penske Media Corporation. India WebPortal Private Limited.
425. Caputi, TL (24 August 2016). "Heat-not-burn tobacco products are about to reach their boiling point". Tobacco Control. 26 (5): 609–610. doi:10.1136/tobaccocontrol-2016-053264. PMID 27558827. S2CID 46170776.
426. Candice Nguyen (1 February 2014). "'E-Hookah' Debuts in San Diego Amid Critics". NBCUniversal.
427. Susie Ochs (20 February 2014). "Blow Hookah: No fire, no charcoal, just vapor and lasers". PC World. TechHive. Archived from the original on 18 March 2017. Retrieved 2 June 2019.
428. Debra Thimmesch (7 October 2014). "Canadian Doctor Promotes a 3D Printed Adapter for Converting Hookahs to E-Hookahs". 3DPrint.com. 3DR Holdings.
429. ^ "3DPI.TV – 3D Printed e-Hookah Adapter Could Help Smokers". 3DPI.TV. 3D Printing Industry. 20 May 2014.
430. Chadi, Nicholas; Minato, Claudia; Stanwick, Richard (June 2020). "Cannabis vaping: Understanding the health risks of a rapidly emerging trend". Paediatrics & Child Health. 25 (Suppl 1): S16–S20. doi:10.1093/pch/pxaa016. PMC 7757764. PMID 33390752.
431. Gaspard Glanz (17 December 2014). "France's First Cannabis E-Cigarette Is Completely Legal". Vice.
432. Alexandra Ma (11 August 2015). "This Is What It's Like To Vape Caffeine". HuffPost.

Bibliography

• McNeill, A; Brose, LS; Calder, R; Bauld, L; Robson, D (February 2018). "Evidence review of e-cigarettes and heated tobacco products 2018" (PDF). Public Health England. UK. pp. 1–243.
• National Academies of Sciences, Engineering, and Medicine; et al. (Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems) (January 2018). Stratton, Kathleen; Kwan, Leslie Y.; Eaton, David L. (eds.). Public Health Consequences of E-Cigarettes. Washington, DC: National Academies Press. doi:10.17226/24952. ISBN 978-0-309-46834-3. PMID 29894118. Retrieved 15 January 2023. Summary
• Wilder, Natalie; Daley, Claire; Sugarman, Jane; Partridge, James (April 2016). "Nicotine without smoke: Tobacco harm reduction". Royal College of Physicians. UK. pp. 1–191.
• McNeill, A; Brose, LS; Calder, R; Hitchman, SC; Hajek, P; McRobbie, H (August 2015). "E-cigarettes: an evidence update" (PDF). Public Health England. UK. pp. 1–113.
• "State Health Officer's Report on E-Cigarettes: A Community Health Threat" (PDF). California Tobacco Control Program. California Department of Public Health. January 2015. pp. 1–21. This article incorporates text from this source, which is in the public domain.
• "Electronic nicotine delivery systems" (PDF). World Health Organization. 21 July 2014. pp. 1–13.
• Linda Bauld; Kathryn Angus; Marisa de Andrade (May 2014). "E-cigarette uptake and marketing" (PDF). Public Health England. UK. pp. 1–19.
• National Center for Chronic Disease Prevention Health Promotion (US) Office on Smoking Health (2014). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Surgeon General of the United States. pp. 1–943. PMID 24455788.

External links

• Media related to Electronic cigarettes at Wikimedia Commons

• Electronic cigarettes
• Cigarette types
• Chinese inventions
• Smoking cessation
• Substance-related disorders
• Non-tobacco nicotine products
• 2003 introductions
• 21st-century inventions